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ABSTRACT 
 
 Herbal plants of the Echinacea genus are used as immunostimulants for treatment of wide 
range of diseases, especially a common cold and upper respiratory tract infections. 
 In this thesis, seven Echinacea commercial products were analysed with high-performance 
liquid chromatography to quantitatively determine caffeic acid derivatives that are responsible 
for the plant healing properties. Determined contents of chlorogenic acid, caffeic acid, 
cichoric acid and echinacoside were compared between individual samples. 
 Further, root and leaf-bloom extracts of Echinacea purpurea were prepared 
with pressurized solvent extraction under different conditions and they were consequently 
analysed to show, which solvent system and temperarure is the most proper for extracting 
the highest amount of caffeic acid derivatives. 
 From the measured data, Imunit Echinaceove kapky from Simply You was chosen as 
the product with the highest total concentation of the content compounds. Extraction at 80 °C 
using EtOH/water = 40/60 was found as the best way giving the highest concentration 
of caffeic acid derivatives from roots as well as leaves and blooms. 
 
ABSTRAKT 
 
 Rostliny rodu Echinacea jsou používány jako léčivé byliny stimulující imunitní systém, 
zvláště v boji proti chřipce a infekcím horních cest dýchacích. 
 V této práci bylo analyzováno 7 komerčních výrobků obsahujících výtažky z rostliny 
Echinacea vysokoúčinnou kapalinovou chromatografií. Bylo provedeno kvantitativní 
stanovení derivátů kyseliny kávové, jež jsou látky zodpovědné za léčivé účinky rostliny. 
Zjištěné obsahy kyseliny chlorogenové, kávové, cichorové a echinakosidu byly porovnány 
v jednotlivých výrobcích. 
 Dále byly připraveny extrakty z kořene, listů a květů třapatky nachové pomocí extrakce 
za zvýšeného tlaku extrakčního rozpouštědla při různých podmínkách. Extrakty byly následně 
analyzovány, aby se z obsahu účinných látek v nich přítomných zjistilo, které extrakční 
podmínky jsou nejlepší. 
 Z naměřených dat bylo zjištěno, že největší celková koncentrace obsahových látek 
je přítomna ve výrobku Imunit Echinaceové kapky firmy Simply You. Jako nejlepší extrakční 
podmínky se ukázaly teplota 80 °C v kombinaci s rozpouštědlem ve složení 
EtOH/voda = 40/60, a to jak při extrakci kořene, tak i listů a květů. 
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1. INTRODUCTION 
 Human immune system is weakened in consequence of a contemporary lifestyle. Stress, 
unbalanced diet, polluted environment, absence of movement, drugs, alcohol, smoking, sleep 
deficiency, pesticides, herbicides, preservatives, flavouring additives and synthetic dyes 
in food belong to the factors that weaken our immune system, that has to be protected 
and reinforced enough, ideally in a natural way [1]. 
 Echinacea spp. (from Greek echinos = spike) is a herbaceous plant belonging 
to Heliantheae tribe of Asteraceae family and used for centuries in folk medicine, both 
in the US, where representatives of Echinacea genus are also known as coneflowers, 
and in Europe [2]. 
 Echinacea is an important medicinal plant native of North America, where its medical 
properties were explored by American Indians, who used mainly Echinacea angustifolia 
and Echinacea purpurea. In following decades, the importance of Echinacea was slowly 
forgotten and it lasted long years until an iterative notice of its extraordinary qualities [3]. 
Extracts obtained from Echinacea species are traditionally used in the formulation 
of herbal medicines and dietary supplements used as immunostimulants in the treatment 
of inflammatory and viral diseases. The drug consists of the roots of E. purpurea, 
E. angustifolia and E. pallida. in the case of E. purpurea, the aerial parts are also commonly 
used in phytotherapy [4]. 
 Chemical analysis of plants in the genus Echinacea has identified seven groups 
of medically important components including caffeic acid derivatives, polysaccharides, 
flavonoids, essential oils, polyacetylenes, alkylamides and miscellaneous chemicals, which 
exhibit diverse pharmacological activities [4, 5]. 
 It is still necessary, in fact, to do more work to clearly identify the different species 
of Echinacea and to distinguish between the efficacy of the different plants 
and of the different plant parts for a better therapeutic use. The individual plant parts contain 
different compounds in a various concentration. The two species E. angustifolia 
and E. pallida are grown or collected mostly for the roots while the aerial parts are used 
in the case of E. purpurea. It was concluded that the roots of E. purpurea do possess 
an antioxidative activity, although less than the roots of E. pallida [6, 7, 8]. 
 Nowadays, Echinacea is widely grown in various parts of world for commercial purpose 
[3]. 
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2. THEORETICAL PART 
 
2.1 Echinacea Species Overview 
 The Echinacea genus includes nine species of herbaceous plants, which are native 
to North America. The species are Echinacea angustifolia (Narrow-leaf Coneflower), 
Echinacea atrorubens (Topeka Purple Coneflower), Echinacea laevigata (Smooth Purple 
Coneflower), Echinacea pallida (Pale Purple Coneflower), Echinacea paradoxa (Yellow 
Coneflower, Bush´s Purple Coneflower), Echinacea purpurea (Purple Conflower, Eastern 
Purple Coneflower), Echinacea sanguinea (Sanguine Purple Coneflower), Echinacea 
simulata (Wavyleaf Purple Coneflower), Echinacea tennesseensis (Tennessee Coneflower). 
The three species E. angustifolia, E. pallida and E. purpurea are those used 
for pharmacology [6, 9, 10]. 
 
2.2 History of Echinacea Species as a Medical Drug 
 The picture of Echinacea using by origin inhabitants of America is incomplete. Because 
Indian nations shared the unique experience in a verbal form, there were no written records 
that would summarize all their knowledge. Experience was transmited from one generation 
to another by a spoken word. Unfortunately, most of knowledge about American herbal plants 
was lost during a period of colonization, when Indians were almost exterminated by European 
colonizators, who did not save precious information. Therefore we know just a fragment 
of medical properties of Echinacea [1]. 
 In historical documents dated from the time of colonization of America, only two species 
of Echinacea are described – Echinacea angustifolia and Echinacea purpurea. E. angustifolia 
grows on the East coast, while E. purpurea appears on the West coast of the United States. It 
is not surprising, that colonizers firstly identified E. angustifolia, which was the first 
Echinacea species mentioned in their botanical lists. The oldest reference to Echinacea can be 
found in a book called Flora Virginica published in 1762 by L.T. Gronovius and that was 
based on a terrain research of English botanic John Clayton living in 1693 – 1773 [1]. 
 At the beginning of the 20th century, a group of individuals realized, that the whole Indian 
culture is in danger. They joined together and asked the Congress to create a Council 
for registration of Indian knowledge before their loss forever. At this request, the Congress 
constituted the Council of American Etnology, whose aim was to record Indian culture 
in good time. Lots of investigators were sent to a terrain to travel around the States and collect 
the information from descendants of famous Indian nations [1]. 
 In spite of the fact, that Echinacea had been known thousands years before it was used 
in Eclectic Medical Schools, we are grateful to Eclectics for Echinacea introduction 
to a medical subconscious. These somewhat untypical physicians carefully investigated all 
Echinacea species and their findings and teaching are an important contribution to modern 
medicine. Beginning of an eclectic motion in medicine falls into the year of 1845, when 
disagreement with former medical practics appeared on the East coast of the United States 
of America. Firstly, Eclectics used Echinacea to the same purpose as Indians, but then, they 
applicated it with a bigger or little success in a permanently growing spectra of all sorts 
of cases [1]. 
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 By 1921, Echinacea preparations belonged to the most widely sold medicines extracts. 
However, the interest about Echinacea disappeared, when the Eclectic Institute was closed. 
In 1930´s, antibiotics were discovered and bacterial diseases, which had killed plenty 
of patients, could be simply healed. Antibiotics represented the best medicament at that time. 
Eclectics reached success with Echinacea in 85 %, antibiotics worked in 100 % of cases. 
Time period between 1930 – 1960 meant time of dark for Echinacea. In 1960 – 1970 
scientific researches were focused on cancer and many herbal plants were investigated. 
Scientists realized, that the immune system is responsible for a control over possible cancer 
cells. If the immune system was stimulated, cancer could be kept under control. Rebirth 
in herbal medicine came in 1980´s. People were disappointed by offical medicine and some 
negative effects of antibiotics forced people to find alternative ways. The herbs started to be 
studied and used again [1, 5, 11]. 
 In 1979, Echinacea was a minor product in the market, but in 1997, the Americans spent 
365 million of dollars on Echinacea products [1]. 
 In 1998, Echinacea was the 10th most important medicinal plant sold in Europe 
with annual sales of 120 million U.S.$. Nowadays Echinacea ranks as number three among 
the top-selling herbal dietary supplements in the United States with the annual sales value 
of more than 32 million U.S.$. Echinacea products account for more than 10 % of the sales 
in U.S. conventional food, drug, and mass market retail stores. In Australia Echinacea is also 
a market leader and in North Africa, South America, and China it is experiencing increasing 
attention [12]. 
 
2.3 Plant Characteristics 
 
2.3.1 Echinacea angustifolia 
 Echinacea angustifolia (Fig. 1) growing to 60 cm high is characterized by violet flowers 
and ray florets as long as or less than width of receptacle. Few footstalks grow up 
from about 30-millimetre-wide root head. Cylindrical roots with the diameter of 15 mm are 
light brown coloured. Cultivation is not very large and wide-spread. Echinacea angustifolia 
grows in the damp places, low bushes, at the edge of moors, in ditches, etc. It blooms 
from July to September [1, 9]. 
 
 
 
Fig. 1 Echinacea angustifolia [13] 
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2.3.2 Echinacea purpurea 
 Echinacea purpurea (Fig. 2) reaches the height of 90 cm. Leaves are ovate with coarsely 
toothing. Basal leaves are often cordate. A root system is fibrous. Its roots are thick and black 
with stridently harsh taste. E. purpurea is widely distributed in Midwestern United States. 
Cultivation is also expanded in Europe and Australia. Echinacea purpurea blooms from July 
to September [1, 9]. 
 
 
 
Fig. 2 Echinacea purpurea [14] 
 
2.3.3 Echinacea pallida 
 Echinacea pallida (Fig. 3) grows to 120 cm high. Its purple ray flowers can reach up 
the lenght of 9 cm. A rootstalk and red-brown roots are cylindrical with a diametre 
from 4 mm to 20 mm. This species of Echinacea is grown not only in America, but also 
in Europe [1, 9]. 
 
 
 
Fig. 3 Echinacea pallida [15] 
 
2.4 Echinacea Extract Properties 
 The extract of coneflower has significant immunomodulatory and antioxidant activities. 
Extracts from Echinacea purpurea shows antioxidative, antibacterial, antiviral and antifungal 
properties. The extracts are used for treating of a common cold, respiratory diseases such 
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as coughs, bronchitis and upper respiratory infections, urinary diseases, and for disorders 
treating such as cutaneous affections and a chronic disease due to a deficiency 
of immunological responses [2, 3, 6, 16]. 
 In the past, Echinacea was generally used, for example, as an antitoxin against a snakebite 
or other poisonous bites and stings. It was used to inhibite toothache, headache, stomache, 
epileptic seizure, spasms as well as on eye inflammation healing and eye diseases, eczema, 
flash burns, hydrofobia or mumps [1]. 
 Accessible documents give two information about application of Echinacea angustifolia as 
a Indians´ medicament. It is known, that Indians used fresh roots. They did not use Echinacea 
in a dry form. Fresh roots were chewed up and a created paste or a juice were utilized. There 
are no available information, which would tell, how many roots were used [1]. 
 H. T. Webster described Echinacea healing properties in his work called A work devoted 
to the Theory and Practise of Specific Medication with special references to the newer 
remedies published in Cincinnati in 1898. According to this book, Echinacea can be applied 
to various problems (Tab. 1). Dr. F. J. Peterson mentions other positive effects of Echinacea 
in his Materia Medica and Clinical Therapeutics published in Los Olivos in 1905 (Tab. 2) 
[1]. 
 
Tab. 1: Healing Properties of Echinacea described by H. T. Webster [1] 
 
Clasification of Problems Disease 
emergent bacterial infections 
child cholera, cholera morbus, diphteria, red pestilence,  
follicular inflammation of tonsils, peritoneum inflammation, 
septicaemia, enteric fever 
chronic bacterial infections intermittent, remittent and chronic fever, syphilis 
protozoal infection malaria 
viral infections morbili, variola, hydrophobia 
poisoning bee sting, poison ivy, rattle-snake bite, poisonous snake bites, tarantula bite 
healing anthrax, furuncle, gangrene, haemorrhoids, throat suppurative inflammation 
autoimmunite disease skin irritation 
 
Tab. 2: Healing Properties of Echinacead described by F. J. Peterson [1] 
 
Clasification of Problems Disease 
emergent bacterial infections 
appendicitis, epidemic cerebro-spinal meningitis, 
diarrhoea, gonorrhoea, pneumonia, childbed fever, 
septicaemia after childbirth 
viral infections tuberculosis 
healing burn, urethrocystitis, coleocystitis, post-operative wounds 
autoimmunite disease eczema 
 
 Harvey Wickes Felter writes about Echinacea effect on cancer and infection of genitals 
in his book called King´s American Dispensatory published in Ohio in 1909. Use 
of Echinacea in gynaecology was described in Dr. S. F. Stephens´s work called 
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The Essentials of Medical Gynecology published in Cincinnati in 1907. This medical 
publication is focused on prevention from catastrofical consequence of voluntary abortions, 
that were secretly done at the beginning of the 20th century [1]. 
 Numerous modern studies show activity of Echinacea purpurea extracts on inhibition 
of hyaluronidase, promoting the formation of mesenchymal mucopolysaccharides, stimulation 
of histogenic and haematogenic phagocytes, promoting differentiation of fibrocytes 
from fibroblasts and stimulating the anterior pituitary-adrenal cortex [9]. 
 Enzyme hyaluronidase decomposes hyaluronic acid maintaining body cells together. 
The extract from Echinacea purpurea breaks hyaluronidase and it leads to a chronic bacterial 
infections fadeaway [1]. 
 Bacteriostatic and fungistatic activity are reported against Staphylococcus aureus, 
Escherichia coli, Pseudomonas aeruginosa, Trichomonas vaginalis and Epidermophyton 
interdigitale. Echinacea purpurea extracts have shown indirect antiviral activity against 
encephalomyocarditis, vesicular stomatitis, influenza, herpes and polyovirus. Further studies 
have suggested that Echinacea could play a therapeutic role in a wide range of clinical 
disciplines including dermatology, pediatrics, gynecology, surgery, urology and the treatment 
of allergies [9]. 
 Experiments have also demonstrated that Echinacea can modulate production of specific 
cytokines from human and rodent macrophages and peripheral blood mononuclear cells 
in vitro and in vivo. Further, it may stimulate proliferation of peripheral blood mononuclear 
cells (PBMC), increase the number of circulating lymphocytes and monocytes and increase 
the percentage of spleen NK cells [17]. 
 
2.5 Active Compounds found in the Herb 
 Echinacea extracts have shown a highly complex chemical composition, including caffeic 
acid derivatives, alkamides, polyacetylenes and polyenes, polysaccharides and glycoproteins, 
which exhibit diverse pharmacological activities. The most important organic compounds 
contained in Echinacea angustifolia, Echinacea pallida and Echinacea purpurea responsible 
for their pharmacological activity are caffeic acid derivatives, alkamides and polysaccharides 
[4, 6]. 
 There are differences among the presence and concentrations of the particular active 
components in above and below ground plant parts and it is necessary to make clear 
the efficacy of these plant parts for better therpeutic use. For instance apart from cichoric acid 
no phenolics are present in the leaf and stem extracts. It is possible to influence secondary 
metabolites content by suitable manipulation of a culture medium and growing conditions like 
temperature, light and other physical factors [2, 3, 7]. 
 There are also differences between treatment effects of Echinacea species. 
The antioxidant activity can be ascribed to the phenolic content of the roots. Phenolic 
substances like caffeic and chlorogenic acid belong to the most efficient antioxidants 
from natural sources, while polyphenols are better antioxidants than monophenolic 
compounds. Additionally, cichoric acid from E. purpurea is almost as efficient 
as echinacoside in E. pallida [7]. 
 A degree of successful radical scavenging by active compounds depends on the structure 
of the active compounds. Substitution of the aromatic ring in ortho- or para-position enhances 
the antioxidant efficacy, because a resonance structure formed by this substitution has 
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a higher stability of the antioxidant radical formed upon scavenging of other radicals. Caffeic 
acid has only one orthodihydroxyphenyl group, while cichoric acid is composed of two 
molecules of caffeic acid [7]. 
 
2.5.1 Caffeic Acid Derivatives 
 The group of caffeic acid derivatives in Echinacea extracts includes five following 
compounds [18]: 
• caftaric acid (2-O-caffeoyl tartaric acid) 
• cichoric acid (2,3-O-dicaffeoyl tartaric acid) 
• cynarin (1,3-dicaffeoyl-quinic acid)  
• chlorogenic acid  
• echinacoside 
 
 The caffeic acid derivatives are typically synthesized by phenylpropanoid pathway, 
in which the phenylalanine ammonia lyase plays a key role in diverging primary metabolism 
from the production of secondary metabolites. For these reasons, it is interesting to study how 
different growing conditions such as the effect of nitrate fertilization, saline stress, incubation 
temperature and photoperiod can improve the accumulation of secondary metabolites. It was 
found that a biomass accumulation and production of caffeic acid derivatives is optimal under 
incubation temperature of 20 °C among the different incubation temperatures tested (10, 15, 
20, 25 and 30 °C). Biomass of adventitious roots is highest in cultures grown under dark 
while the accumulation of caffeic acid derivatives is optimum in the cultures grown under 
3/21 h light and dark cultural regimes. Overall, root tissues show much higher contents 
of chlorogenic acid, echinacoside, cynarin and cichoric acid than did the leaves. Cynarin 
and cichoric acid are the phenols in the roots of Echinacea angustifolia at the highest 
concentration [6]. 
 
2.5.1.1 Caffeic acid 
 Caffeic acid (Fig. 4) is a non-flavanoid catecholic compound abundantly present in many 
plants and occurs in diet as part of fruits, tea, coffee and wine. It is effective as a treating 
agent because of its antioxidant capacity, free radical scavenging and chelation 
of metal ions. These effects may be attributed to the presence of a catechol group 
and double bond in its side chain. In addition, caffeic acid also exhibits a wide range 
of pharmacological activities such as inhibition of enzyme activity, antitumor activity, 
anti-inflammatory effect and inhibition of HIV replication [19]. 
 
 
 
Fig. 4 Caffeic acid [20] 
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2.5.1.2 Caftaric acid 
 Caftaric acid (Fig. 5) is an ester formed from caffeic and tartaric acids. It is the most 
abundant nonflavonoid phenolic compound in grapes and wines. It occurs in chicory and is 
one of the bioactive components of Echinacea purpurea [21, 22]. 
 
 
 
 
 
Fig. 5 Caftaric acid [23] 
 
2.5.1.3 Cichoric acid 
 Cichoric acid (Fig. 6) has shown immunostimulatory properties, promoting phagocyte 
activity in vitro and in vivo. In addition, cichoric acid has antihyaluronidase activity, and has 
a protective effect on the free radical-induced degradation of collagen. Cichoric acid has also 
shown antiviral activity and has recently been found to inhibit HIV-1 integrase 
and replication [3]. 
 Cichoric acid can be present in the plant in the concentration up to 20 mg in 1 g of dry 
matter. The difference of the cichoric acid content in one of Echinacea species can be four 
times higher in comparison with the other ones. The content of cichoric acid and the other 
compounds depends on harvest-time, the way of drying and plant material extraction. 
The thriftiest way of drying is lyophilisation. Losses of cichoric acid are about 10-15 % 
during drying with hot air at the temperature of 40 ºC. The losses get higher by a temperature 
increase. They are about 80 % at 70 ºC. It was observed that concentration of the active 
compounds is higher in the plant when growing in the presence of nitrogen excess [8]. 
 
 
 
Fig. 6 Cichoric acid [24] 
 
2.5.1.4 Chlorogenic acid 
Chlorogenic acid (Fig. 7), structurally the ester of caffeic acid with the 3-hydroxyl group 
of quinic acid, is an antioxidant and an inhibitor of the tumor promoting activity of phorbol 
esters. Chlorogenic acid can be used as the anti-infectious active ingredient. It has wide anti-
virus and anti-bacteria effects, and has relatively lower toxicity and side-effects. It has 
obvious anti-infectious effects and does not like to lead anti-microbial resistance [25]. 
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Chlorogenic acid and caffeic acid are antioxidants in vitro and might therefore contribute 
to the prevention of Type 2 Diabetes Mellitus and cardiovascular disease and it also slows 
the release of glucose into the bloodstream after a meal [25]. 
Due to its obvious anti-infectious effects, it can be used as in a pharmaceutical field as 
in many other fields like food, feed additives and cosmetics [25]. 
 
 
 
Fig. 7 Chlorogenic acid [26] 
2.5.1.5 Cynarin 
In 1987, the polyphenolic compound 1,3-dicaffeoylquinic acid known as cynarin 
(Fig. 8) was determined in Echinacea angustifolia composition. No other Echinacea species 
contain cynarine and that is why this compound is unique. It exhibits hypocholesterolemic, 
hepatoprotective and antioxidative activity. Cynarin can be formed from 1,5-dicaffeoylquinic 
acid by intramolecular transesterification during the solvent extraction of plant material. 
According to researching works, cynarine intensively works upon the liver and protects them 
against the insult. It has following effects: bile secretion increase from the gall-bladder, bile 
forming increase in the liver, cholesterol degradation, liver protection from the insult, 
cholesterol level decrease and lipid level decrease in blood [1, 27]. 
Dicaffeoylquinic acids (DCQAs) have been recently established as a class 
of HIV-integrase inhibitors, which represent a key area in developing of a new antiretroviral 
therapy and which are currently used in combinations for treatment of HIV-1 infection 
or AIDS. HIV-integrase is a virus-encoded enzyme that catalyses an essential step 
in the replication of HIV, insertion of the proviral double-stranded DNA into the host 
chromosome for its efficient replication. HIV-integrase is a promising target 
for the development of highly selective anti-HIV agents. Dicaffeoylquinic acids as a new class 
of HIV-1 inhibitors block strongly and irreversibly HIV-1 integration in biochemical assays. 
They also block viral replication at nontoxic concentrations in tissue culture. For this reason, 
they are considered to be an attractive target for new drug development as a novel HIV 
therapeutic agent [27, 28]. 
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Fig. 8 Cynarin [29] 
 
2.5.1.6 Echinacoside 
Echinacoside (Fig. 9) is a hydrophilic compound that represents the main phenolic 
component in E. angustifolia and E. pallida roots. As a natural product echinacoside showes 
good antioxidant and anti-hepatotoxic activities. It also displays neuroprotective activities 
with free radical scavenging [30]. 
 
 
 
Fig. 9 Echinacoside [31]  
 
2.5.2 Verbascoside 
In 1988, verbascoside was found in leaves of Echinacea angustifolia. Verbascoside has 
a similar chemical composition to echinacoside and cancels usual inflammatory reactions. 
Presence of verbascoside in the plant roots explains the ability to hold down the inflammation 
associated with poisonous bites [1]. 
 
2.5.3 Polyacetylenes and Polyenes 
Polyacetylenes and polyenes are a class of natural products that are known as potent 
antifungal and antibacterial compounds. They are inhibitors of some enzymes, such as 
cholesterol acyltransferase. Several experiments have indicated that some polyacetylenes 
might exhibit antiallergenic and anti-inflammatory activities. They support phagocytosis 
and thanks to the immunity cells stimulation, they manage to remove poisonous toxins 
from the body. In addition, polyacetylenes have proven to be cytotoxic against a number 
of solid and leukemic cancer cell lines and they inhibite activities of Escherichia coli, 
Pseudomonas aeruginosa and Trichomonas vaginalis [1, 32]. 
Modern researches confirm the polyacetylenes lose their antibacterial properties during 
a long-lasting storage. It means Echinacea should be used in a fresh state [1]. 
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2.5
rated aliphatic acid residue linked with different amine moieties. 
alkamides have been isolated thus far from nature. The presence 
of 
strative like bitterness or weak burning in mouth 
wh
If seedling aerial parts are sprayed with 100 ppm methyl 
jasm
It appears that the immune-stimulating effects of Echinacea result from polysaccharides 
s and thereby they provide protection from bacterial and pathogenic 
aride components have also been shown to promote tissue 
reg
lar weight component is 
a h
 a mean Mr of 75.000 
[5].
 Glycoproteins 
It was established that the root system of Echinacea pallida contains two macromolecules: 
an arabinogalactan-protein (AGP) and an arabinan. The arabinogalactan-proteins are formed 
.4 Alkamides 
Alkamides as lipophilic constituents are a distinct class of natural products containing 
mostly an unsatu
Aproximately 200 
alkamides in Echinacea has been known for almost half a century. The olefinic 
isobutylamides are the most biologically active alkamides contained in Echinacea. 
The abundance of these compounds varies with organ type and plant age. Some alkamides are 
often used as one of the diagnostic patterns for identification of E. angustifolia roots 
in commercial preparations  [33, 34, 35]. 
The alkamides alone show no antioxidant activity, however, they increase 
the antioxidative effect of cichoric acid in the peroxidating lipid emulsion. Their presence can 
be uncovered by strange feelings demon
en chewing plant roots [1, 7]. 
Methyl jasmonate, as an alkamides representative and a naturally-occurring plant cellular 
signal molecule, was found to induce production of lipophilic secondary metabolites 
in Echinacea pallida seedlings. 
onate, lipophilic root extracts obtained 24 hours after spraying and separated by HPLC, 
reveal a significant increase in six alkamides or related ketoalkene/ynes produced 
by 34 day-old plants and in seven compounds produced by 58 day-old plants [36]. 
 
2.5.5 Polysaccharides 
surrounding of tissue cell
invasion. The polysacch
eneration by stimulating fibroblasts and inhibiting the enzyme hyaluronidase, which 
breaks down the intracellular cement formed by hyaluronic acid [5]. 
The carbohydrate fraction extracted from E. angustifolia radix is constituted by two 
polysaccharides with molecular weight of about 128.000 and 4.500 Da. The low molecular 
weight polysaccharide corresponds to inulin while the high molecu
igh metoxy pectin in which the backbone structure of the smooth region is constituted 
by α-(1–4)-polygalacturonan partially methyl esterified (60 %) and acetylated (9 %) 
and with the hairy regions containing 2-O- and 2,4-O-rhamnopyranose, 5-O- and 3,5-O-
arabinofuranose, 3,6-galactopyranose, and terminal rhamnopyranose, arabinofuranose, 
arabinopyranose, galactopyranose, and galacturonopyranose. Mass spectrometry data 
of a galactanase treated sample showed evidence of a novel structure in the pectin hairy 
region, namely a galactose-galacturonic acid alternating sequence [5]. 
Three different polysaccharides with immunestimulating properties have been isolated 
from E. purpurea and characterized: two neutral fucogalactoxyloglucans with mean molecular 
mass of 10.000 and 25.000 g·mol-1 and an acidic arabinogalactan with
 
 
2.5.6
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by high carbohydrate and a small protein moiety. The carbohydrate part constitutes more 
tha
e AGP molecule was also formed by uronic 
acid
E. purpurea grown in eastern Serbia was analyzed to determinate the presence of trace 
elements and their content in different parts of the plant. The concentration of trace elements 
>Mg>Fe>Mn>Cu>Zn>Sr>Ni>Li. It was discovered that flowers 
con
Roots, stems, leaves and flowers of Echinacea angustifolia, E. pallida and E. purpurea 
have been analyzed for volatile components. As a result, over seventy compounds have been 
irrespective of the species, contain acetaldehyde, dimethyl 
sulf
n 90 % of the arabinogalactan-protein molecule. Less than 10 % is formed by a protein 
part. Investigations of the neutral sugar composition revealed Gal (52.1 % w/w) and Ara 
(38.2 % w/w) in a ratio of 1.4:1, accompanied by Glc (6.9 % w/w) and Rha (2.8 % w/w). 
The content of uronic acids was 6.2 %. The protein part (3.9 % w/w) of the AGP is 
characterized by high amounts of Hyp (17.3 %), Ser (11.4 %), Ala (9.6 %), Thr (8.9 %), Glu 
(8.6 %), Asp (7.3 %) and Gly (7.0 %). Minor components were Val (5.6 %), Lys (4.2 %), Leu 
(3.9 %) and Pro (3.4 %). Traces of Isoleu, Met, Phe, His, Tyr and Arg were also found. The 
arabinan mainly consists of Ara (85.8 %) accompanied by some Glc (7.7 %), Rha (3.9 %) 
and traces of Gal and Man (together 2.6 %) [37]. 
In the other investigation, the arabinogalactan-protein was isolated from Echinacea 
purpurea herb. A high amount of polysaccharide (83 %) with a ratio of galactose (59.1 %) 
to arabinose of 1.8:1 was present. Some part of th
s (4–5 %) and a low protein content with high levels of serine, alanine 
and hydroxyproline. The amino acid composition of the protein component of the AGP was 
characteristic for AGPs and typically rich in Ser (16.0 %), Ala (12.5 %), Hyp (11.5 %), Asx 
(10.6 %), Thr (10.5 %), and Glx (9.4 %). Minor amounts of Arg (7.5 %), Gly (4.6 %), Val 
(4.1 %), His (3.7 %), Lys (3.3 %), Leu (2.5 %), Ile (2.2 %) and Phe (1.6 %) were also 
detected [38]. 
 
2.5.7 Trace Elements 
decreased as follow: Ca
tain the highest concentration of Cu, Zn and Ni, while the concentration of Mg, Ca, Fe, 
Mn, Li and Sr is the highest in leaves [39]. 
 
2.5.8 Volatile Components 
identified. All plant tissues, 
ide, camphene, hexanal, β-pinene and limonene. The main volatile constituents 
of the aerial parts of the plant are β-myrcene, α-pinene, limonene, camphene, β-pinene, 
trans-ocimene, 3-hexen-1-ol and 2-methyl-4-pentenal. The major volatile components of root 
tissue are α-phellandrene (present only in the roots of E. purpurea and E. angustifolia), 
dimethyl sulfide, 2-methylbutanal, 3-methylbutanal, 2-methylpropanal, acetaldehyde, 
camphene, 2-propanal and limonene. Aldehydes, particularly butanals and propanals, make up 
41-57 % of the headspace of root tissue, 19-29 % of the headspace of the leaf tissue, and only 
6-14 % of the headspace of flower and stem tissues. Terpenoids including α- and β-pinene, 
β-myrcene, ocimene, limonene, camphene, and terpinene make up 81-91 % of the headspace 
of flowers and stems, 46-58 % of the headspace of the leaf tissue, and only 
6-21 % of the roots [40]. 
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2.5.9 Essential Oils 
The major constituents of seed oils are three isomers of tocopherols and fatty acids. 
-isomer forms about 83 % of the total amount of tocopherols, while the β-isomer constitutes 
ount of tocopherols. γ-tocopherol appears only in Echinacea 
ol oil content differs significantly among species. E. angustifolia 
pro
ermacrene D, caryophyllene, caryophyllene epoxide, 
α-p
idate free 
dicals and destroy some dangerous enzymes. Three the most interesting flavanoids present 
olia are luteolin, kaempferol and quercetin [1]. 
terized by antihistaminic, anti-inflammatory, antioxidative and diuretic 
pro
d bactericidal qualities. 
It a
 contamination by heavy metals, 
oil and soil-borne organisms, herbicides and pesticides. In this sense, hydroponics may 
or the standardized production of high-quality plant 
, in particular for those medicinal plants, such as 
Ech
roper and the most economics way of herbal plants conservation is 
drying. During the optimal drying all the content compounds are preserved in unchanged 
α
only about 17 % of the total am
angustifolia. Tocopher
duces the highest content of tocopherols in comparison with the other two species, while 
E. pallida forms more tocopherols than E. purpurea. The oil is highly polyunsaturated. 
The most abundant fatty acids of Echinacea seed oil are linoleic, oleic and palmitic acids, 
which together comprise 95 % of the total fatty acid. The fatty acid profile of Echinacea seed 
oil is similar to safflower oil. The research has also showed the presence of vitamin E 
in the range of 29 to 85 mg in 100 g oil. Vitamin E content in Echinacea seed oil is similar 
to peanut, olive and soybean oils [41]. 
When sniffing freshly dried roots of Echinacea angustifolia, characteristic odour evoked 
by essential oils is smelled. The amount of these oils is small. In fact, it is about 1 % of all 
compounds. But that is still enough to produce a penetrating scent. Essential oils including 
palmic acid, borneol, bornyl acetate, g
inene, β-pinene, myrcen, limonene and 1,8-pentadecadiene have antibacterial, antifungal 
and antiviral properties. Essential oils´ feature is their volatileness. Therefore tinctures should 
be stored in a well-closed bottles made of coloured glass to prevent evaporation [1]. 
 
2.5.10 Flavanoids 
Flavanoids provide the ability to reduce capillary fragility and permeability, liqu
ra
in Echinacea angustif
Luteolin is charac
perties as well as by preventative qualities against cancer. Kaempferol shows similar 
characteristics to luteolin together with the ability to inhibit retroviruses and HIV virus. 
Quercitin has among others antiallergic, antihydrofobic, antiviral an
lso helps in a fight with a cold, HIV virus and cancer [1]. 
 
2.6 Plant Processing into Drugs 
For pharmaceutical use, the plant material must be free of
s
provide a suitable growing system f
material containing active principles
inacea angustifolia, which are cultivated mainly for the roots and are difficult to grow 
in the open field. In addition, hydroponics also allows regulation of secondary metabolism 
involved in the accumulation of pharmacological active principles, by opportune management 
of nutrient solutions [6]. 
The first requirement for obtaining a good quality drug from harvested material is its 
quick conservation that stops or inhibits dissociative processes as a consequence 
of interruption of a natural metabolic equilibrium in plant parts separated from a mother 
herbal plant. The most p
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qua
ying of curative plants in the sun after the harvest is not a proper way. The better one is 
dry
res that could 
dep
ed or which are intended for preparation of a tea mixture are sliced up to get a required 
size
a drugs storing is keeping a low relative 
hum
 The relative humidity should be about 
65 
way of desinsection is 
a t
 break down the collagen fibres 
into fragments. That is a similar effect to destruction, that happens to skin, which is 
 the Sun. Therefore, this radical negative effect 
d intaken of anti-oxidants. If the collagen fibres are 
mix
ntity and the plant saves its good appearance that is often an indication point of  quality 
[42]. 
The rate of drying depends on temperature and relative humidity of air. High temperatures 
speed up the drying but they also inhibite enzyme activity. Enzymes usually denaturate 
at the temperatures above 50 °C. A temperature limitation is determined by pharmaceutical 
important content compounds that can decompose, volatilize, oxidate etc. [42]. 
Dr
ing in a shadow in well-ventilated conditions or in dryers, where the usual drying 
temperature is about 60 – 70 °C. Drugs determined to packing must not contain any water 
[42]. 
After drying the drugs are sorted to remove inadmissible parts or admixtu
reciate the product. The drugs are separated according to their size by netting and they are 
homogenized to get portions with the same quality. Homogenization is a process when 
the drugs are carefully mixed together without grinding.The drugs from which a tea drink is 
prepar
. Some drugs are used in a powder form [42]. 
Except of drying, there are other possibilites how to conserve the plants such as freezing, 
chemical conservation or ensilaging for example [42]. 
The drugs are stored mostly in paper covers or in cardboard, wooden or plywood boxes. 
Hydroscopic drugs are protected against the air humidity by a plastic material or they are kept 
in tinny vessels. The basic requirement during 
idity of the air, stable low temperatures if it is possible, prevention of a direct sunlight 
contact with drugs and penetration of pests into a store.
% and temperature values should be at intervals of 5 – 15 °C [42]. 
It is necessary to shield the stored drugs from pests. The biggest danger is represented 
by insect. Gases like methylbromide and trihydride phosphorus are used for a complete 
desinsection of all developmental stages of insect. The desinsection can be done in two ways. 
It is possible to treat the storing space or to treat the drugs that are placed in the open covers 
into a well-sealing room into which the gas is blown. The other 
emptation of insect followed by its destruction. The temptation is realized by proper 
hormons or with a light of a determined wavelength [42]. 
 
2.7 Echinacea as a Skin Formula 
Strength of skin, tendons and ligaments is determined by collagen fibres, while oxygen 
radicals as destructive chemicals in the human body
over-exposed to the ultraviolet radiation from
is about to be mitigated by an increase
ed with echinacoside and caffeoyl conjugates contained in Echinacea, the collagen is 
nearly completely protected from a free radical-induced degradation. Perhaps coincidentally, 
Echinacea ointments are quite popular in Europe to treat skin problems including sun burns 
and wounds [43]. 
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2.8 Dosage of Echinacea Preparations 
Eclectics used tinctures made of fresh roots in a form of concentrated solutions consisted 
of one part of fresh Echinacea roots and one part of alcohol (1:1) or weaker solutions 
s. Success of treatment in some cases depends 
priate amount that guarantees antitoxic affect 
to v
 every two or three hours for at least time, during which 
xins, have also been considered to be safe [1]. 
o use Echinacea, should begin with very small quantities. 
 the course of a cold, for example, it is good to take a high medicament dose in quantities 
of 2
o use Echinacea 
for 
that the herb is about as dangerous as a glass of water. 
xtremely high doses of Echinacea extract have been given to laboratory animals, with little 
on or toxicity. In the recommended dosage, Echinacea does not 
 unfavourable effects were described at pregnant and nursing 
wo
hromatography is based on a passage of constituents to be 
eparated between two immiscible phases. For this, the sample is dissolved in a liquid mobile 
in the rate of 1:5. They also used single root
on a regular medicament intake in the appro
iral infections. Eclectics recommended to take Echinacea in the following amount [1]: 
• tincture 1:1 = 3 mL daily 
• tincture 1:5 = 15 mL daily 
• fresh roots = 3 g daily 
• dried roots = 1.5 g daily 
 
High doses like 3.54 g to 16 g
the body is contaminated by to
People, who have decided t
In
00 mg five times a day to improve a healthy state quickly. In the case of other infections, 
200 mg three or four times a day is enough. Sometimes it is recommended t
at most eight days and continue in usage after the eight-days break. The other source 
mentions to use Echinacea for a period of 5 to 10 days, after which Echinacea intake should 
be discontinued for a couple of weeks. This might be a way to strengthen 
the immune system and lower the risk of getting sick. This pattern might also limit 
the symptoms of a cold or flu-like illness which someone has already contracted. Constraining 
of the primary intake to no more than 10 days of continued use could also be a way to evade 
the problem of lost benefits or potential immune suppression associated with regular 
long-term use of the herb. The intake of too much Echinacea or overly extended use 
of the product might actually reduce its effectiveness or even suppress the immune system 
a bit. Echinacea can be used with or without the food. However, the possitive effect 
of Echinacea treats on a relatively short-term basis. Therefore it is suitable to use 
the Echinacea products in short time intervals during the emergent infection [11, 43]. 
Nowadays Echinacea is available in various forms such as pastilles, softgels, dried herb 
and tea, tinctures and capsules. The most favourite one is a form of tablets made 
of a powdered root material [11]. 
 
2.9 Contraindications 
A variety of studies indicate 
E
evidence of tumour inducti
show any side effects. No
men. In humans suffering from allergy to flowers from Asteraceae family, an allergic 
reaction can appear [11, 43]. 
 
2.10 High-Performance Liquid Chromatography 
The principle of liquid c
s
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phase. All the constituents travel the same route through the separation bed and due 
to 
. In external chromatograms, it is located in the value of the retention 
tim
ust always realize that the peak capacity of a column is 
lim
 
The solvents used as a mobile phase are stored in a reservoir in glass or stainless steel 
bottles. Dissolved gases, which can lead to the formation of bubbles or suspend matter, must 
 sucking the solvents through a milliporefilter under vacuum 
[44
There are several types of pumping system. Displacement pumps work like a syringe. 
A specific volume - approximately 200 mL - of the mobile phase is sucked in and discharged 
he HPLC system. Reciprocating pumps are preponderant today. They 
are
the specific interactions with the stationary phase they are separated and they appear 
at the end of a column at different times. Compounds retained more strongly on the stationary 
phase take longer time to be separated than substances which are less strongly interactive. 
In the case of HPLC, separation is based on four principles including adsorption, distribution, 
ion exchange and exclusion. Ideally, the substances are separated after a certain elution time 
and are individually detected at the end of the column. In column chromatography, 
the recording of the detector signal as a function of elution time or elution volume is 
a chromatogram [44]. 
Chromatographic methods are used both for qualitative and quantitative analysis. 
In internal chromatograms, qualitative information is located in the position of a substance 
on the stationary phase
e or the retention volume [44]. 
Coupling of chromatographic separation with spectroscopic detectors is undertaken 
to accurately identify unknown substances. In qualitative chromatographic analysis 
of multicomponent mixtures one m
ited. Peak capacity reflects the number of peaks which can be resolved in a lining-up 
of peaks on a defined spacing. The basis of quantitative analysis in column chromatography is 
the evaluation of the height or the area of a peak. The chromatographic methods are relative 
methods. A calibration takes place through the analysis of standard substances. When 
evaluating peak height it must be guaranteed that no alterations in peak form arise due 
to changing chromatographic conditions. Variables, such as column temperature, flow rate 
and the volume of injection must be precisely controled [44]. 
The HPLC unit consists of a mobile phase solvent reservoir, a pump system, a sample 
feeding or an injection system, possibly of a precolumn, a separation column and a detector 
[44]. 
A. Mobile Phase Degassing 
be removed for insistance by
]. 
 
B. Pumping System 
free of pulsation into t
 operated as double piston pumps, which work with a phase shift of 180° to suppress 
pulsation. To avoid a direct contact of the solvent with the pump valves, the pumps are also 
available as piston diaphragm pumps. Here the piston movement is transfered to a diaphragm 
using hydraulics [44]. 
Better separation is often achieved with a gradient than an isocratic elution. Gradients can 
be produced on the low pressure or high pressure side. If one mixes the two or three solvents 
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of a
displacement in the range between 
0.1
. Injection System 
The sample injection must allow volumes in the range of 5 to 500 µL to be introduced. 
 should be kept in the system. Sample injection systems work 
aut
D. olumn 
The inside of columns consists preferentially of polished stainless steel. There are also 
e of heavy-walled glass typing. The standard column is 250 mm long, 
wit
. Detectors 
Detectors with high sensitivity are required in high-performance liquid chromatography, 
nsitivities in the microgram to nanogram range. Widely used detectors are 
refr
e used with solvents that have significant 
abs
.11 Extraction and Isolation of Active Compounds 
It is necessary to transform the plant into a suitable form before the extraction 
d in tap water, rapidly rinsed 
in d
e of 70:30 v/v 
n eluent on the suction side of a pump, one refers to a low pressure gradient. Two pumps 
are required to produce a high pressure gradient [44]. 
The requirements for pumps for HPLC are manifold – generation of pressure up 
to 15 MPa, slight residual pulsation, constant 
 and 10 mL.min-1, reproducibility and control of the flow with a relative error of less than 
0.5 % and chemical resistance. Therefore, the pumps are made of stainless steel, teflon 
or ceramics [44]. 
 
C
In addition, pressure
omatically and they are preferred for high precision in sample introduction [44]. 
 
C
columns mad
h an inner diameter of 4.6 mm, filled with particles whose diameter is 5 or 10 µm [44]. 
 
E
usually with se
actometer detectors and  ultraviolet detectors that have much better sensitivity 
about 10-8 g.mL-1 (0.01 ppm), while the refractometer ones detect concentrations 
of about 10-5 to 10-6 g.mL-1 (10 to 1 ppm) [44]. 
UV detectors are not temperature sensitive, it is relatively inexpensive, and can be used 
with gradient elution. Of course it cannot b
orption in the UV or with sample components that do not absorb in the UV [44]. 
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of compounds. Fresh plants chosen for analysis are washe
eionised water, dried with a towel and then separated into roots, leaves and inflorescences. 
Subsequently,the samples are dried at 50 °C in a ventilted oven and maintained in desiccators 
until they are analysed for selected metabolites, generally not later than a couple of weeks 
after sampling. Different drying methods, such as freeze-drying (FD), vacuum microwave 
drying (VMD), and air-drying (AD), are applied to fresh roots and leaves. Dried tissue is 
chopped or grinded in a blender to get a powder, that is mixed with an extraction solvent 
and prepared for HPLC analysis. Seeds of Echinacea must be firstly grounded 
in a coffee grinder and then the loose oil is extracted using hexane as an appropriate solventin 
the amount of 150 mL of hexane corresponding to 50 g of a sample [6, 41, 45]. 
Various mixtures can be used as an extraction solvent system. Good results can be 
reached with the extraction solvent consisting of methanol and water in the rat
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to i
 liquid extracts. Most of the research has been carried 
out
nd flower heads) lies in the extraction carried out by using CO2 
and
n of samples 
wit
itrile 
for 
acetic acid in nanopure water and (B) HPLC 
gra
) water + 0.03 mol.dm-3 phosphoric acid and (B) 
ace
rotein precipitation 
of 
solate chlorogenic acid, echinacoside, cynarin and cichoric acid. Dry powdered roots can 
be extracted with boiling water for 10 min (0.1 g.mL-1) to isolate fructans. Isolation 
of arabinan and AGP from a powdered drug material can be carried out after 16 hours-long 
maceration in an aqua dam. AGP has also been isolated from a high molecular weight fraction 
of pressed juice of Echinacea purpurea herb by precipitation with the β-glucosyl Yariv´s 
reagent. Extraction in Soxhlet apparatus lasting several hours using n-hexane as a solvent is 
applicable for polyacetylenes and polyenes determination from the root tissue. Oil content 
of the ground Echinacea seed samples can be analysed by Soxhlet extraction with petroleum 
ether for 6 hours [4, 6, 37, 38, 41, 46]. 
Experts are divided on whether it's best to ingest pieces of whole root, powdered 
Echinacea in capsule or tablet form, or
 with the liquid, alcohol-based extracts rather than the dry stuff, and many devotees believe 
that Echinacea constituents are best protected from spoilage in liquid-extract form. However, 
some experts have contended that the alcohol in extracts might break down Echinacea 
beneficial polysaccharides. A glycerol-based Echinacea extract is now available to get around 
this potential problem [47]. 
One of the possible methods of determination of active compounds from Echinacea dry 
aerial parts (stems, leaves a
 CO2 + ethanol mixture. With this method, high levels of alkamides have been extracted. 
Ethanol as a co-solvent substantially increases the yield, but also increases the extraction 
of undesirable colour components and high molecular weight waxes. The yield is both 
pressure and temperature dependent, and increases with both parameters [48]. 
Extracted samples must be processed to a form, which is possible to use for HPLC 
analysis. This process generally includes procedures such as dilutio
h the appropriate volume of a dissolving agent to get a standardized concentration, 
centrifugation and filtration through a 2.5 cm diameter, 0.45 µm PTFE membrane syringe 
filter or 0.2 μm nylon filter. Prepared samples can be injected for HPLC analysis [6, 18]. 
For determination of caffeic acid derivatives, water and acetonitrile can be used as 
a mobile phase. The gradient elution is 10 % acetonitrile for 40 minutes, 25 % aceton
next 11 minutes, 50 % acetonitrile for 1 minute following by a recycle to initial conditions 
for 8 minutes with a flow rate 0.3 mL.min-1 [3]. 
Other alternative leading to the determination of caffeic acid derivatives and alkamides 
supposes sample injection of 5 μL and uses (A) 
de acetonitrile as a mobile phase. A flow rate is 0.2 mL.min-1 and the gradient is as 
follows: t = 0-4 minutes, 90 % A (10 % B); t = 4–15 minutes, 90–60 % A (10–40 % B); 
t = 15–30 minutes, 60–40 % A (40–60 % B); t = 30–35 minutes, 0 % A (100 % B); 
t = 35–43 minutes, 90 % A (10 % B) [16]. 
Caffeic acid derivatives and alkamides can also be successfuly determined  
with the developing solvent consisted of (A
tonitrile + 0.03 mol.dm-3 phosphoric acid. The solvent gradient is 5–45 % B linearly 
for 20 min followed by 45–100 % B linearly for 20–25 min. A 10 µl sample is injected each 
time and pumped through the column at a flow rate of 1.0 mL.min−1 [49]. 
A rapid and simple high-performance liquid chromatographic method has been developed 
and validated for the determination of echinacoside in rat serum. After p
serum sample with trichloroacetic acid, the supernatant is directly injected and analyzed 
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with a mobile phase consisting of acetonitrile and 0.5% acetic acid (15.5:84.5, v/v). 
The mobile phase is used throughout the analysis at a flow rate of 1.0 mL.min-1 [30]. 
11 main alkamides present in Echinacea purpurea roots can be analysed as methanolic 
ext
copherols occuring in Echinacea seed oil are determinable by HPLC. As a mobile 
pha
le summarizing the parameters mentioned above (Attachment 9.1). 
2.12 Detection of Active Compounds 
 for a particular Echinacea constituents detection 
inv
isible spectroscopy 
 and attenuated total reflection infrared spectroscopy 
tion and flame atomic emission spectrometry 
High-performance liquid chromatography paired with UV detection has been developed 
for 
 array UVspectrophotometric detection has also 
bee
a seed oils analyzed by HPLC system have been 
det
ea purpurea has been studied to distinguish elemental 
pat
ction infrared spectroscopy 
(AT
racts subjected to reversed phase HPLC analysis using a gradient elution 
from acetonitrile/water 40/60 (v/v) to 80/20 (v/v) in 40 minutes at a flow rate of 1.0 mL.min-1 
[33]. 
To
se, hexane/2-propanol/dimethylpropane (1000/5/1, v/v/v) have been used at a flow rate 
of 1 mL.min-1 [41]. 
Enclosed is a tab
 
Wide range of analytical methods is used
olving [4, 50]: 
• ultraviolet-v
• infrared spectroscopy 
• near infrared reflection
• nuclear magnetic resonance 
• mass spectrometry 
• flame atomic absorp
 
determination of alkamides as lipophilic compounds at wavelengths of 210, 254 
and 260 nm. Hydrophilic compounds such as phenolics, chlorogenic acid, cichoric acid 
and echinacoside have been detected at 326 and 330 nm. Caffeic acid derivatives 
and alkamides is possible to detect simultaneously when using high-performance liquid 
chromatography coupled with UV photodiode-array detection and electrospray ionization 
mass spectrometry (ESI-MS) [18, 33, 49, 51]. 
Capillary electrophoresis using photodiode
n employed for the simultaneous analysis of caffeic acid derivatives and alkamides 
absorbing UV radiation at 210 nm [16, 35]. 
α-, ß-, γ- and δ-tocopherols in Echinace
ected by fluorescence detector excitation and emission using wavelengths set 
at 297 and 325 nm, respectively [41]. 
Elemental composition of Echinac
terns. The content of Zn, Fe, Cu, Mn, Ca, Mg, Sr, Ni, and Li is determinable by flame 
atomic absorption and flame atomic emission spectrometry [39]. 
Near infrared reflection (NIR) and attenuated total refle
R-IR) methods are developed to determine the echinacoside content in roots of Echinacea 
angustifolia and Echinacea pallida. Based on the recorded spectra and the HPLC reference 
data, chemometrical analyses are performed using a partial least squares (PLS) algorithm. 
Generally, good calibration statistics are obtained for the prediction of the echinacoside 
content presenting comparatively high coefficients of determination and low root mean 
standard errors of cross validation. In contrast to the time-consuming HPLC method, 
the described non-destructive measurements allow to predict the echinacoside content already 
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after an analysis time of approximately one minute. According to the research developed 
to detect echinacoside in rat serum, the ultraviolet detector is effective. The UV spectrum 
of echinacoside has two absorption maxima at 218 and 330 nm. By the wavelength of 330 nm 
greatest sensitivity with minimal interference is achieved [50]. 
Near-infrared (NIR) reflectance spectroscopy was used to develop a fast identification 
me
 species 
(E.
 chromatography, other analytical methods are available 
for 
capillary zone electrophoresis 
y 
aphy 
llar electrokinetic chromatography 
y/mass spectrometry 
ass spectrometry 
phy 
Capillary zone electrophoresis due to its high-resolution separation and versatility, has 
bec
sed juice of Echinacea purpurea herb can be 
isolated from a highmolecular weight fraction by precipitation with the β-glucosyl Yariv´s 
reagent, followed by gel-permeation chromatography [38]. 
thod for Echinacea purpurea dried milled roots. The aim of this qualitative analysis is 
to confirm the identity of E. purpurea and to detect the presence of fraud, i.e., samples 
adulterated or substituted by Echinacea angustifolia, Echinacea pallida or Parthenium 
integrifolium. Specificity is demonstrated by testing a validation set against the method. NIR 
spectroscopy is a good tool for the fast identification of E. purpurea roots if the samples are 
milled using the same procedure as for the calibration samples. The method is robust 
with respect to the origin of the samples and can be used routinely by the pharmaceutical 
industry or herbal suppliers to avoid mislabeling errors or adulteration [51]. 
Comparison of chemical components and antioxidants capacity of three Echinacea
 purpurea, E. angustifolia and E. pallida) has been done by HPLC directly coupled 
to ultraviolet absorbance and electrospray mass spectrometric detectors. The method permits 
rapid characterization and tentative identification of a large number of caffeoyl conjugates 
and alkamides from alcoholic extracts of the roots and leaves of the herbs. The roots 
of the three species differs markedly in their contents of characteristic compounds. Cichoric 
acid and verbascoside predominate in extracts of E. purpurea root while cynarine and dodeca-
2E,4E,8Z,10Z/E-tetraenoic acid isobutylamide are the major chemicals characteristic 
of E. angustifolia root extracts. Echinacoside and 6-O-caffeoylechinacoside predominate 
in extracts of E. pallida roots [52]. 
Except high-performance liquid
the Echinacea constituents analysis including following ones, while the last two methods 
are used for active compounds identification in dietary supplements and commercial products 
[53]: 
• 
• gel-permeation chromatograph
• reversed-phase liquid chromatogr
• thin layer chromatography 
• cyclodextrin-modified mice
• gas chromatography/mass spectrometry 
• liquid chromatography/mass spectrometr
• fast atom bombardment and fast atom bombardment tandem m
• reversed-phase high-performance liquid chromatography 
• cyclodextrin-modified micellar electrokinetic chromatogra
• ultrasonic extraction and liquid chromatography 
 
ome an effective alternative to HPLC for the separation of charged analytes. This method 
is employed with a great success for the simultaneous analysis of caffeic acid derivatives 
and alkamides from Echinacea extracts [16, 54]. 
The arabinogalactan-protein (AGP) from pres
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Reverse phase liquid chromatography (RP-LC) method with DAD-detection has been 
validated to quantify caffeic acid derivatives in various Echinacea species [55]. 
A fast, simple and sensitive qualitative TLC method was developed to identify Echinacea 
pal
 fluorescence 
at 
CD-MEKC). Hydrophobic alkamides interact 
stro
constituents responsible for the antihyaluronidase activity 
of E
ea purpurea. The method 
con
 sodium 
dod
lida radix. This method, based on the lipophilic compounds of E. pallida, uses three 
mobile phases providing good separation. A marker substance shows a blue
an excitation wavelength of 366 nm after detection with a spray agent containing 
95 volume parts of 96% ethanol, 5 parts of 99% trifluoroacetic acid and zinc ions 
in 0.15 molar concentration. After spraying, the chromatogram was heated at 110 °C 
for 7 min. In this version, the method is superior to HPLC methods to characterise mixtures 
of Echinacea extracts in terms of selectivity due to this post-chromatographic derivatisation 
and subsequent fluorescence detection [56]. 
Separation of nine important alkyl methylbutyl- and isobutylamides known as alkamides 
obtained from Echinacea purpurea extracts was investigated by using cyclodextrin-modified 
micellar electrokinetic chromatography (
ngly with the micelles from the most common surfactants used in MEKC and this leads 
to a predominant partition of the analytes into the micellar phase, resulting in poor resolution. 
The addition of neutral CDs to the alkaline (10 mmol.dm-3 phosphate buffer, pH 8,0) micellar 
system of sodium dodecyl sulfate (SDS), sodium cholate (SC) and sodium deoxycholate 
(SDC) was found to improve the separation of the studied alkamides [57]. 
An analytical GC-MS method based on nonpolar fused silica capillary column was 
developed to analyze the lipophilic constituents, mainly alkamides, from the root extracts 
of Echinacea purpurea [58]. 
Fast atom bombardment - mass spectrometry (FAB-MS) and fast atom bombardment 
tandem mass spectrometry (FAB-MS-MS) techniques have been successfully applied 
for identification of the 
chinacea angustifolia roots, whose extracts are widely employed for the adjuvant therapy 
of chronic inflammatory diseases. Crude extracts from different solvents were tested 
for antihyaluronidase activity and those with the greatest inhibitory action (the ethylacetate, 
butylacetate and chloroform fractions) were directly analyzed by MS. 2,3-O-dicaffeoyltartaric 
acid (chicoric acid), 5-O-dicaffeoylquinic acid (cynarine) and 2-O-caffeoyltartaric acid 
(caffaric acid) in the ethylacetate fraction as main caffeoyl conjugates were detected 
and identified by tandem mass spectrometry. Among these caffeoyl conjugates, chicoric 
and caftaric acids had the greatest antihyaluronidase activity [59]. 
A reversed-phase high-performance liquid chromatography method has been developed 
to determine caffeic acid derivatives, for example, cichoric acid, and alkamides 
simultaneously in plant parts and herbal products of Echinac
sists of an extraction procedure whereby the hydrophilic phenolics as well as the lipophilic 
alkamides are released from the samples, followed by the analytical HPLC procedure 
for quantitative determination of these compounds. The method is the first one validated 
for the determination of these two groups of compounds in the same procedure [60]. 
Cyclodextrin-modified micellar electrokinetic chromatography (CD-MEKC) has been 
applied to Echinacea spp. in combination with pattern recognition of some caffeoyl solutes. 
The CD-MEKC method using hydroxypropyl-beta-cyclodexrin (HP-beta-CD) with
ecyl sulphate in a triacid background electrolyte (pH 8) under 19 kV has been adapted 
to identify two key hydrophilic solutes: chlorogenic acid and cichoric acid present 
in all commercial products [61]. 
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Analytical methodologies with ultrasonic extraction and liquid chromatography (LC) have 
been developed for the determination of phenolic compounds in dietary supplements 
containing Echinacea. The phenolic compounds determined by these methods include caftaric 
acid
Pressurized solvent extraction (PSE) was developed for its application in natural product 
extraction in recent years. PSE works with organic and/or aqueous solvents at high 
ching up to 200 °C speed up the extraction rate, 
wh
pounds. 
Inc
needed for methods 
 mples, 
, 
or extraction of various biological materials. 
, chlorogenic acid, cynarin, echinacoside, and cichoric acid. Samples from tablets, 
capsules and bags of tea blends is possible to extract [62]. 
 
2.13 Pressurized Solvent Extraction 
temperature and pressure. Temperatures rea
ile elevated pressures with values from 3.5 to 20 MPa prevent boiling at temperatures 
above a normal boiling point of the solvent, that flows through a stainless steel extraction cell 
containing a solid sample [63, 64, 65, 66, 67]. 
A principle of PSE lies in a solvent heating to increase solubilization, i.e. extraction 
efficiency is increased. Under isobaric conditions, the solvent reaches its boiling point and it 
turns into a gas. A gaseous state of the solvent loses its ability to dissolve com
reasing the pressure in the system leads to a return of the gas back to a liquid state [67]. 
 Consequently, PSE method includes following advantages [65, 67]: 
• keeping solvents below their boiling point enables a great improvement of solvating 
 power and extraction efficiency, 
• by possibility of using most of solvents, minimal time is 
development compared to the other solvent extraction techniques, 
• short time is needed to prepare sa
• dramatic reduction of solvent usage, 
• concentrated extracts for simplified post extraction processes, 
• less solvent waste, 
• small size of a device body, 
• simple computer interfacing saves time and increases precision
• PSE has been used f
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3. EXPERIMENTAL PART 
, Karlsruhe, Germany), Mr = 180.16 
- Chlorogenic acid hemihydrate, purity >98 % (Fluka Chemie GmbH, Steinheim, 
id (AppliChem GmbH, Ottoweg, Germany), Mr = 474.38 
0 
.04 
- s.r.o., Neratovice, Czech Republic), Mr = 60.05 
ient Pump, ECOM, spol. s.r.o., Czech Republic 
- LCD 2084.2 UV-VIS Detector, ECOM, spol. s.r.o., Czech Republic 
- LCO 101 Column Oven, ECOM, spol. s.r.o., Czech Republic 
luation: Clarity™ Chromatography Station 
 
3.1 Chemicals 
- Caffeic acid 99 % (Alfa Aesar
 Germany), Mr = 363.32 
- Cichoric ac
- Echinacoside (AppliChem GmbH, Ottoweg, Germany), Mr = 786.7
- Methanol (Sigma-Aldrich Laborchemikalien GmbH, Seelze, Germany), Mr = 32
Acetic acid (Lach – Ner, 
- Deoinized water 
 
3.2 HPLC Instruments and Accessoires 
- LCP 4100.2 Grad
- Software equipment for a data eva
for Windows, DataApex, Prague, Czech Republic 
 
 
 
Fig. 10 ECOM HPLC Instruments 
 
- UV-Vis spectrophotometer, Helios Sloha, Waltham, USA 
- Microfilters – OEM Filter Nylon 0.45 µm, Sigma-Aldrich Chemie GmbH, Germany 
- Syringes (2 mL) – CHIRANA Injecta, a.s., Slovak Republic 
- Micropipette Eppendorf Research – 100 – 1000 µL, 500 – 5000 µL, Eppendorf, USA 
epublic - Ultrasound Bath - K5 Kraintek, s.r.o., Podhajska, Slovak R
- Analytical balance AND GR – 202, A&D Instruments Company LTD., Japan 
- Microtubes 1.5 mL, Gama, a.s., Czech Republic 
- one PSE – Applied Separations, Inc., Allentown, USA 
 31
 
 
Fig. 11 one PSE 
3.3 Analysed Commercial Products 
Seven products available in chemist´s (Fig. 12, 13, 14, 15, 16, 17, 18) and twelve extracts 
(Fig. 31, 32, 33) prepared under different conditions with pressurized solvent extraction from 
a dry herbal drug were analysed to compare a content of caffeic acid derivatives and a total 
concentration of present compounds. 
 
Name of Product:  Echinaceove bylinne kapky (Fig. 12) 
Producer:   Aromatica, v.o.s., Slapanice, Czech Republic 
Description: alcoholic extract of Echinacea purpurea containing at least 40 % vol. 
of ethanol 
Dosage: 20 drops three-times a day 
 
 
 
Fig. 12 Echinaceove bylinne kapky 
 
Name of Product:  Echinacea Aktiv bylinne kapky (Fig. 13) 
Producer:   Aromatica, v.o.s., Slapanice, Czech Republic 
Description: alcoholic extract of Echinacea roots, Penax ginseng and Lenzea 
carthamoides containing at least 40 % vol. of ethanol 
Dosage: 20 drops three-times a day 
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Fig. 13 Echinacea Aktiv bylinne kapky 
 
Name of Product:  Echinacea Forte (Fig. 14) 
Producer:   Dr. Theiss Naturwaren GmbH., Homburg, Germany 
Description: alcoholic extract of a fresh juice from Echinacea purpurea (0,03 mL 
of juice in one drop) containing 22 % vol. of ethanol 
Dosage:  children at the age of 3-6: 3 drops once to twice a day 
 children at the age of 6-12: 5 drops once to three-times a day 
children older than 12 years and adults: 25 drops three- to four-times 
a day 
 
 
 
Fig. 14 Echinacea Forte 
 
Name of Product:  Echinacea Kräutertropfen (Fig. 15) 
Producer: Dr. Theiss Naturwaren GmbH., Homburg, Germany 
Description: alcoholic extract of Echinacea angustifolia (100 g of the extract 
contains 33 g of a herb) 
Dosage: children at the age of 2-6: 3 drops twice a day 
 children older than 6 years: 5 drops twice a day 
 adults: 20 - 50 drops twice a day 
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Fig. 15 Echinacea Kräutertropfen 
 
Name of Product:  Imunit Echinacea kapky (Fig. 16) 
Producer:   Simply You, a.s., Opava, Czech Republic 
Description: alcoholic extract of Echinacea purpurea roots with addition of blooms 
containing at least 45 % vol. of ethanol 
Dosage:  20 drops three-times a day 
 
 
 
Fig. 16 Imunit Echinacea kapky 
 
Name of Product:  Succus Echinaceae (Echinaceae purpureae herbae succus) (Fig. 17) 
Producer:   Phytopharm Kleka S.A., Nowe Miasto nad Warta, Poland 
Description: alcoholic extract of Echinacea purpurea containing 20 - 30 % vol. 
of ethanol 
Dosage: children at the age of 7 – 12: 10 drops a day 
adults: 20 – 40 drops three-times a day 
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Fig. 17 Succus Echinaceae 
 
Name of Product:  Echinaceove bylinne kapky Mgr. Hajkove (Fig. 18) 
Producer:   Mgr. Magda Hajkova, Brno, Czech Republic 
Description: alcoholic extract of Echinacea purpurea roots and blooms containing 
at least 40 % vol. of ethanol and 100 mg of effective compounds 
Dosage: children under the age of 3: 10 drops diluted by 150 mL of water once 
a day adults: 20 drops three-times a day 
 
 
 
Fig. 18 Echinaceove bylinne kapky Mgr. Hajkove 
 
3.4 Plant Material 
Name of Product:  A dry herbal drug of Echinacea purpurea (Fig. 19, 20) and extracts 
made of this drug by pressurized solvent extraction 
Producer of the drug: Frutarom Ltd., Wädenswil, Switzerland 
 
 35
    
 
Fig. 19 Leaves and blooms of E. purpurea   Fig. 20 Roots of E. purpurea 
 
3.5 Preparation of Samples for the Analysis 
 
3.5.1 Preparation of Standard Solutions 
 Chemically pure standards of chlorogenic acid, cichoric acid, caffeic acid 
and echinacoside had been chosen as those compounds, whose content was determined 
in available Echinacea products and extracts. 
 Standard substances were weighted on an analytical balance with the accuracy of 0.1 mg. 
Then they were solved in 1.7 mL of deoinized water in the ultrasound bath to obtain 
homogenous solutions. From these stock solutions, less concentrated solutions were prepared 
by a sequential dilution. Needed volumes were pipetted with micropipettes and after filling 
to the volume of 1.7 mL with deionized water, the samples were shaken. Each following 
dilution was made in the same way. Finally, such prepared solutions were injected for HPLC 
analysis.  
 Six solutions from each of standard substances were prepared in the concentration intervals 
of 3 – 15 µg.mL-1 of chlorogenic acid, 10 – 100 µg.mL-1 of caffeic acid, 10 – 150 µg.mL-1 
of cichoric acid and 3 – 117.65 µg.mL-1 of echinacoside to construct the calibration curves. 
 Concentrations of individual standard solutions are shown in Tab. 5, 6, 7, 8 in the part 
Results and Discussion. 
 
3.5.2 Preparation of Commercial Products 
 Echinacea products representing liquid alcoholic extracts were filtered through Nylon 
microfilters (0.45 µm) to prevent an eventual column plugging. All the samples, except 
for Dr. Theiss´s Kräutertropfen drops, were diluted 10-times with deionized water, because 
they were too concentrated. Dr. Theiss´s Kräutertropfen drops did not have to be diluted 
necessarily. Final volume of stock solutions was 25 mL. Prepared solutions were injected 
for HPLC analysis. 
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3.5.3 Preparation of PSE Extracts 
 Pressurized solvent extraction was used to prepare extracts from leaves, blooms and roots 
of Echinacea purpurea. Two mixtures of ethanol and water in different rates were used 
as solvent systems in combination with three temperatures at a constant pressure to show 
the influence of temperature and a solvent composition on the amount of extracted 
compounds. 
 The first solvent system (ethanol/water = 60/40, v/v) was tested at 40, 60 and 80 °C 
as well as the second solvent system (ethanol/water = 40/60, v/v). For the extraction, 0.5 g 
of a dry plant material was used. The process run under the pressure of 15 kPa in two cycles 
over a period of 2 x 10 minutes. The system was rinsed with nitrogen for 20 seconds between 
each cycle and 2 minutes after the last cycle. Volume of a cartridge filled with a sample and 
an inert support was 11 mL. 
 In this way, 12 samples were prepared. The next procedure of samples adjustment was 
identical with a preparation of Echinacea products. The extracts were filtered through Nylon 
microfilters (0.45 µm) and diluted up to 6-times depending on their individual concentrations. 
Prepared samples were injected for HPLC analysis. 
 Tab. 3 shows conditions under which the extracts were prepared. Tab. 11 in the part 
Results and Discussion shows that the extracts were diluted up to six-times for the analysis. 
 
Tab. 3: Conditions of Pressurized Solvent Extraction 
 
Sample 
Number 
Vial 
Label 
Temperature 
of Extraction 
[°C] 
Solvent 
EtOH/water 
[v/v] 
Plant 
Material 
Amount of 
extracted 
Material 
[g] 
Time of 
Extraction
[min] 
A1 1Ka 60/40 
A2 1Kb 
40 
40/60 
B1 2Ka 60/40 
B2 2Kb 
60 
40/60 
C1 3Ka 60/40 
C2 3Kb 
80 
40/60 
roots 
D1 1LKa 60/40 
D2 1LKb 
40 
40/60 
E1 2LKa 60/40 
E2 2LKb 
60 
40/60 
F1 3LKa 60/40 
F2 3LKb 
80 
40/60 
leaves, 
blooms 
0.5 2 x 10 
 
3.5.4 Preparation of a Mobile Phase 
 As a mobile phase, the system of methanol/water was used with an addition of acetic acid 
to reach acid pH. A composition of the mobile phase was as follows: methanol/water/acetic 
acid = 25/75/1. Every newly prepared mobile phase was put into the ultrasound bath 
for 10 minutes to be de-aerated. 
 
 37
3.6 Method of the Analysis 
 Rightly diluted and filtered samples were analysed by high-performace liquid 
chromatography. When optimizing the analysis, conditions that have already been applicated 
in the research were used [8, 68]. 
 Analyses were performed using Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm) 
that was heated to 35 °C in a column oven. Isocratic elution run using a mixture of methanol 
and water in a ratio of 25:75 with an addition of 1 % of acetic acid as a mobile phase. Flow 
rate was set at 1.0 mL.min-1 and the injection volume was 10 µL. Chromatograms were 
recorded at the wavelength of 330 nm chosen on the base of an absorption spectrum 
measurement of the caffeic acid standard solution. Detection at 330 nm showed the highest 
absorption of the solution, therefore this wavelength was used for the analyses. 
 Every morning, a pump was rinsed with the mobile phase until all bubles of the air were 
removed. Then the whole chromatography system was rinsed for 15 minutes before 
the analyses. Between the individual analyses, the system was rinsed for 5 minutes. All 
analyses were made three-times.  
 
3.7 Determination of Standard Substances 
 Standards of chlorogenic acid, cichoric acid, caffeic acid and echinacoside were analyzed 
to create appropriate calibration curves as a dependence of the peak areas 
on the concentrations. Preparation of the standard solutions is described in Cap.3.5.1. Every 
calibration curve was constructed from six points, while each point of the calibration curve 
was calculated as the average value from three measurements. A linear part 
of the calibration curves was expressed in a mathematical form by a linear regression. 
 
3.8 Calculations 
Concentrations of caffeic acid derivatives in Echinacea products and PSE extracts were 
calculated from regression equations of calibration curves as dependences of peak areas 
on concentrations of standard solutions (Cap. 4.3 – 4.6). 
 Standard deviation (1) of values of peak areas were calculated and expressed in percents 
[69]. 
 
( )
1
2
−
−= ∑
n
xx
s i          (1) 
 
 For a data evaluation, Clarity™ Chromatography Station and Microsoft Office Excel 
application were used. 
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4. RESULTS AND DISCUSSION 
 
4.1 Identification of Chemically Pure Standards 
 Peak identification of caffeic acid derivatives was made by an addition of a standard 
substance to the real samples. Chromatograms of solutions, to which the standards were 
added, were compared with chromatograms of real samples without standard addition to find 
the differences between individual peak areas. A peak that showed  a higher value of its area 
was established as that one, which was looked for. 
 By this way, it was possible to determine only chlorogenic acid and echinacoside, whose 
peaks could be identified easily. The average retention time of chlorogenic acid was 
6.682 min. The average retention time of echinacoside was 17.356 min. 
 Peaks of caffeic and cichoric acids were not able to be identified with a high accuracy, 
because their retention times were almost identical. From a recorded chromatogram 
(Attachment 9.2) it is obvious that under isocratic elution and used analysis parameters, 
retention time of both cichoric and caffeic acids is approximately 10 minutes and the 
standards can not be separated on the column. 
 A lower flow rate was used to find out, if the separation of cichoric and caffeic acids would 
be more successful. A mixed standard solution consisted from cichoric and caffeic acids was 
injected for HPLC analysis at the flow rates of 0.7 mL.min-1 and 0.5 mL.min-1. Evidently, the 
best result was reached with 0.5 mL.min-1 when the standards were totaly separated and 
caffeic acid was eluted before cichoric acid (Attachment 9.3). Considering this, the flow rate 
of 0.5 mL.min-1 was applied to one Echinacea product (Aromatica – bylinne kapky), but no 
separation was studied. 
 
Tab. 4: Retention Times of Standards of Caffeic Acid Derivatives 
 
Standard Substance Retention Time (min.) 
chlorogenic acid 6.682 
caffeic acid 8.962 
cichoric acids 9.556 
echinacoside 17.356 
 
 From Tab. 4 it is evident that isocratic elution is not a proper method for determination of 
all caffeic acid derivatives and a gradient elution should be applied. 
 
4.2 Determination of Chlorogenic Acid Standard 
 There are average values of the peak areas corresponding to concentrations of water 
solutions of chlorogenic acid and standard deviations in Tab. 5. In Fig. 21, there is  
a graphical expression of the dependence of the peak area on the concentration. 
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Tab. 5: Values of Peak Areas of Chlorogenic Acid Standard Solutions 
 
No. of 
Standard 
Solution 
Concentration of Chlorogenic 
Acid Solution (µg.mL-1) 
Peak Area 
(mV.s) 
Standard 
Deviation (%) 
1 3 157.925 0.888 
2 5 274.629 1.731 
3 7 472.558 4.168 
4 9 610.841 0.688 
5 12 774.524 0.378 
6 15 957.227 2.462 
Calibration Curve of Chlorogenic Acid in Water
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R2 = 0.9913
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Fig. 21 Calibration Curve of Chlorogenic Acid in Water 
 
4.3 Determination of Caffeic Acid Standard 
 There are average values of the peak areas corresponding to concentrations of water 
solutions of chlorogenic acid and standard deviations in Tab. 6. In Fig. 22, there is  
a graphical expression of the dependence of the peak area on the concentration. 
 
Tab. 6: Values of Peak Areas of CaffeicAcid Standard Solutions 
 
No. of Standard 
Solution 
Concentration of Caffeic Acid 
Solution (µg.mL-1) 
Peak Area 
(mV.s) 
Standard 
Deviation (%) 
1 10 1313.860 2.702 
2 20 2538.057 0.598 
3 30 4074.345 3.660 
4 50 6615.479 1.287 
5 80 11311.270 2.437 
6 100 13182.045 2.256 
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Calibration Curve of Caffeic Acid in Water
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Fig. 22 Calibration Curve of Caffeic Acid in Water 
 
4.4 Determination of Cichoric Acid Standard 
 There are average values of the peak areas corresponding to concentrations of water 
solutions of chlorogenic acid and standard deviations in Tab. 7. In Fig. 23, there is  
a graphical expression of the dependence of the peak area on the concentration. 
 
Tab. 7: Values of Peak Areas of Cichoric Acid Standard Solutions 
 
No. of Standard 
Solution 
Concentration of Cichoric 
Acid Solution (µg.mL-1) 
Peak Area 
(mV.s) 
Standard 
Deviation (%) 
1 10 498.510 2.749 
2 40 2322.677 0.027 
3 70 4375.967 3.137 
4 90 5550.090 1.481 
5 110 7490.025 2.086 
6 150 10792.244 0.525 
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Fig. 23 Calibration Curve of Cichoric Acid in Water 
 
4.5 Determination of Echinacoside Standard 
 There are average values of the peak areas corresponding to concentrations of water 
solutions of chlorogenic acid and standard deviations in Tab. 8. In Fig. 24, there is  
a graphical expression of the dependence of the peak area on the concentration. 
 
Tab.8: Values of Peak Areas of Echinacoside Standard Solutions 
 
No. of Standard 
Solution 
Concentration of Echinacoside 
Solution (µg.mL-1) 
Peak Area 
(mV.s) 
Standard 
Deviation (%) 
1 3.00 142.259 4.882 
2 7.00 399.091 0.655 
3 10.00 524.246 0.371 
4 50.00 2760.885 1.015 
5 90.00 5263.444 0.294 
6 117.65 7349.367 0.417 
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Calibration Curve of Echinacoside in Water
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Fig. 24 Calibration Curve of Echinacoside in Water 
 
4.6 Determination of Caffeic Acid Derivatives Content in Echinacea Products 
 Concentrations of the key substances in Echinacea products and PSE extracts were 
calculated from regression equations of the calibration curves. Concentrations of caffeic 
and cichoric acids were determined as a sum of their individual concentrations 
from the regression equation of caffeic acid, because as described in Cap. 4.1, it was not 
possible to distinguish their peak areas.  
 In the case of PSE extracts, separation on the column was not effective enough 
to determine neither chlorogenic acid nor caffeic or cichoric acids. Therefore, only 
concentration of echinacoside was established. 
 Tab. 9, 10 and 11 show the contents of wanted substances. 
 
Chlorogenic acid (Fig. 21): 
9913.0R
044.31333.67
2 =
−= xy
 
 
Caffeic acid (Fig. 22):  
9965.0R
125.5881.135
2 =
−= xy
 
 
Echinacoside (Fig. 24):  
9971.0R
7.111622.61
2 =
−= xy
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Tab. 9: Overview of Chlorogenic and Echinacoside Contents in Echinacea Products 
 
Chlorogenic Acid Echinacoside Name 
of Product Dilution Peak Area 
(mV.s) 
Concentration 
(µg.mL-1) 
Peak Area 
(mV.s) 
Concentration 
(µg.mL-1) 
Simply You - 
Imunit 
Echinacea 
kapky 
10 443.469 70.473 721.350 135.187 
Aromatica - 
bylinne kapky 10 393.144 62.999 432.501 88.313 
Dr. Theiss - 
Echinacea Forte 10 909.354 139.664 406.645 84.117 
PhytoPharm 
Succus 
Echinaceae 
10 795.616 122.772 315.282 69.291 
Mgr. Hajkova - 
Echinaceove 
bylinne kapky 
10 272.263 45.046 200.923 50.732 
Aromatica - 
Aktiv 10 152.473 27.255 226.777 54.928 
Dr. Theiss – 
Kräutertropfen 0 483.038 7.635 234.868 5.624 
 
Tab. 10: Overview of a Common Content of Caffeic and Cichoric Acids in Echinacea 
Products and a Total Compounds Content detected at 330 nm 
 
Caffeic and Cichoric Acids 
Name of Product Dilution Σ Peak Area 
(mV.s) 
Σ Concentration 
(µg.mL-1) 
Total Peak 
Area (mV.s) 
Simply You - Imunit 
Echinacea kapky 10 11931.355 882.813 19638.432 
Aromatica - bylinne 
kapky 10 7987.013 592.382 16252.295 
Dr. Theiss - Echinacea 
Forte 10 1761.915 134.014 10472.077 
PhytoPharm - Succus 
Echinaceae 10 2616.469 196.936 9802.582 
Mgr. Hajkova - 
Echinaceove bylinne 
kapky 
10 1750.962 133.207 8455.523 
Aromatica - Aktiv 10 3085.911 231.503 6214.302 
Dr. Theiss - 
Kräutertropfen 0 1089.893 8.453 7869.406 
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Tab. 11: Overview of Echinacoside Content in PSE Extracts and Total Peak Areas 
 
Echinacoside Sample 
Number Dilution 
Total Peak Area
(mV.s) Peak Area 
(mV.s) 
Concentration 
(µg.mL-1) 
A1 0 15868.322 190.985 4.912 
A2 2 17769.944 390.749 16.307 
B1 2 10034.719 242.392 11.492 
B2 2 5743.634 158.650 8.774 
C1 2 19294.878 467.080 18.785 
C2 2 27312.370 625.770 23.935 
D1 2 22213.820 243.927 11.542 
D2 2 11205.463 192.730 9.881 
E1 4 10404.479 231.683 22.290 
E2 4 14229.277 362.776 30.799 
F1 4 16581.200 301.112 26.796 
F2 6 16633.959 230.118 33.282 
 
4.7 Comparison of Echinacea Products 
 The highest content of all compounds was found in Imunit Echinacea kapky from Simply 
You. A little bit lower concentration was present in Echinaceove bylinne kapky 
from Aromatica. The other products demonstrated a much lower content of all present 
compounds. However, their content is comparable in Echinacea Forte from Dr. Theiss, 
Succus Echinaceae from PhytoPharm, Echinaceove bylinne kapky from Mgr. Hajkova 
and Aktiv from Aromatica. Absolutely the lowest concentration was found in Kräutertropfen 
from Dr. Theiss (Fig. 25). 
 Considering the fact that the first five products were made of Echinacea purpurea, this 
herb offers a higher content of the effective compounds then the other Echinacea species 
when extracted. 
 The total content of compounds in the products also refers to a recommended daily intake. 
20 drops three times a day is enough in the case of the first two products. The other products 
are recommended to be applied in higher amounts. 
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Comparison of Total Peak Areas of Individual Echinacea  Products
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Fig.25 Comparison of Total Peak Areas of Individual Echinacea Products 
 
 The interesting comparison is in the case of chlorogenic acid. Despite of the highest 
content of all compounds in Imunit Echinacea kapky, its chlorogenic acid content is 
with the other products markedly behind the content in Echinacea Forte and Succus 
Echinaceae (Fig. 26). 
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Fig. 26 Comparison of Chlorogenic Acid Concentration in Individual Echinacea Products 
 
 On the other hand, caffeic and cichoric acids content was highest in Imunit Echinacea 
kapky. Echinaceove bylinne kapky from Aromatica contained somewhat lower concentration 
of these derivatives, but it was still significantly much higher amount than in the other 
products (Fig. 27). 
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Comparison of Caffeic and Cichoric Acids Concentrations in Individual 
Echinacea  Products
0
100
200
300
400
500
600
700
800
900
1 2 3 4 5 6 7
No. of Product
C
on
ce
nt
ra
tio
n 
 (µ
g.
m
L
-1
)
1 - Simply You - Imunit Echinacea kapky 
2 - Aromatica - bylinne kapky
3 - Dr. Theiss - Echinacea Forte
4 - PhytoPharm - Succus Echinaceae 
5 - Mgr. Hajkova - Echinaceove bylinne kapky 
6 - Aromatica - Aktiv
7 - Dr. Theiss - Krautertropfen
 
 
Fig.27 Comparison of Caffeic and Cichoric Acids Concentrations in Individual Echinacea 
Products 
 
 Differences in echinacoside content were not so big between most of products. The best 
result was showed by Imunit Echinacea kapky again with a high distinction. As expected, 
the lowest concentration was in Dr. Theiss´s Kräutertropfen (Fig. 28). 
Comparison of Echinacoside Concentration in Individual Echinacea Products
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Fig. 28 Comparison of Echinacoside Concentration in Individual Echinacea Products 
 
 Representation of individual caffeic acid derivatives with regard to a total content 
of compounds in Echinacea products is shown in Tab. 12 and in Fig. 29. High content 
of caffeic acid derivatives in Aromatica Aktiv is probably caused by a presence of other herbs 
in the product, not only by Echinacea. 
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Tab.12: Representation of a Caffeic Acid Derivatives Content with regard to a Total Content 
of Compounds in Echinacea Products 
 
Content Representation (%) 
Name of Product Total peak 
Area 
Chlorogenic 
Acid 
Σ Cichoric and 
Caffeic Acids Echinacoside 
Simply You - Imunit 
Echinacea kapky 100 2.258 60.755 3.673 
Aromatica - bylinne 
kapky 100 2.419 49.144 2.661 
Dr. Theiss - 
Echinacea Forte 100 8.684 16.825 3.883 
PhytoPharm - Succus 
Echinaceae 100 8.116 26.692 3.216 
Mgr. Hajkova - 
Echinaceove bylinne 
kapky 
100 3.220 20.708 2.376 
Aromatica - Aktiv 100 2.454 49.658 3.649 
Dr. Theiss - 
Krautertropfen 100 6.138 13.850 2.985 
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Fig. 29 Representation of a Caffeic Acid Derivatives Content with regard to a Total Content 
of Compounds in Echinacea Products 
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4.8 Determination of a Total Compounds Content and Echinacoside Content 
in PSE Extracts 
 Samples prepared from the herbal material by pressurized solvent extraction were analysed 
by HPLC to find out the best conditions of the extraction. The conditions are described 
in Cap. 3.5.3 in detail. 
 Samples marked with the index a in the Fig. 31- 33 were extracted in solvent containing 
60 % of ethanol and 40 % of water, while samples marked with the index b (Fig. 31- 33) were 
extracted in a mixture consisted of 40 % of ethanol and 60 % of water. Marks A, B, C 
(Fig. 30) describe root extracts and marks D, E, F (Fig. 30) describe leaves and blooms 
extracts of Echinacea purpurea. 
 It is obvious that the most concentrated samples were obtained when extracting at 80 °C 
(samples C, F, Fig. 30). It holds for root extracts as well as for leaves and blooms extracts 
independently on the solvent composition. Looking at the solvent composition, a higher 
content of water was more propitious (samples C2, F2, Fig. 30). 
 When extracting at 40 °C and 60 °C, conclusion is not so evident. Temperature of 40 °C 
was more suitable for the solvent system with 60 % of water in the case of roots (A1, A2, 
Fig. 30). For leaves and blooms, it is better to use more alcoholic solvent (D1, D2, 
Fig. 30). 
 The opposite situation happend at 60 °C, when more alcoholic solvent was better for root 
extraction (B1, B2, Fig. 30), but not for extraction of leaves and blooms (E1, E2, 
Fig. 30). 
 Generally, when comparing the total content of the effective compounds in the root 
and leaf-bloom extracts, more compounds were extracted from the aerial part of the plant. 
From Fig. 30, it is clear that the temperature influence is much higher in the case 
of solvent with 60 % of water than when using the mixture with 60 % of ethanol. 
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index 1 - EtOH/water = 60/40
index 2 - EtOH/water = 40/60
A - root extracts, 40°C
B - root extracts, 60°C
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D - leaf-bloom extracts, 40°C
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Fig. 30 Comparison of a Total Compounds Content in PSE Extracts 
 
 The highest content of echinacoside was found in the leaf-bloom extract prepared 
at 80 °C in the solvent system composed of 40 % of ethanol and 60 % of water (sample F2, 
Fig. 31). When using ethanol/water = 40/60, high echinacoside amounts with small 
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differences were observed in the individual leaf-bloom extracts prepared at 60 °C 
and 80 °C (samples E2, F2, Fig. 31). Generally, higher temperature showed better results than 
lower one. Extraction of roots gave the highest content of echinacoside running 
in ethanol/water = 40/60 as a solvent system at 80 °C (sample C2, Fig. 31). There 
the echinacoside content was remarkably different compared to the other root extracts, except 
of sample C1 (Fig. 31) in which the similar concentration of echinacoside was found. 
 Values of the peak areas of the content compounds and concentrations 
of echinacoside are shown in Tab. 11 (Cap. 4.6). 
 
Comparison of Echinacoside Content in PSE Extracts
0
5
10
15
20
25
30
35
A1   B1   C1   D1   E1   F1 A2   B2   C2   D2   E2   F2
No. of Sample
C
on
ce
nt
ra
tio
n 
(µ
g.
m
L
-1
)
 
index 1 - EtOH/water = 60/40
index 2 - EtOH/water = 40/60
A - root extracts, 40°C
B - root extracts, 60°C
C - root extracts, 80°C
D - leaf-bloom extracts, 40°C
E - leaf-bloom extracts, 60°C
F - leaf-bloom extracts, 80°C
 
Fig. 31 Comparison of Echinacoside Content in PSE Extracts 
 
 In Fig. 32, 33, and 34, there are Echinacea extracts showing visible colour differences 
indicating variative concentrations of compounds released from the herbal drug. Samples 
labeled LK have a more expressive colour indicating a presence of  leaves and blooms 
pigments. 
 
 
 
Fig. 32 Echinacea extracts (40 °C; K = roots; LK = leaves, blooms 
 a = EtOH/water = 60/40; b = EtOH/water = 40/60) 
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Fig. 33 Echinacea extracts (60 °C; K = roots; LK = leaves, blooms; 
a = EtOH/water = 60/40; b = EtOH/water = 40/60) 
 
 
 
Fig. 34 Echinacea extracts (80 °C; K = roots; LK = leaves, blooms; 
a = EtOH/water = 60/40; b = EtOH/water = 40/60) 
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5. CONCLUSION 
 In this study, high-performance liquid chromatography was used for a quantitative 
determination of caffeic acid and its derivatives including chlorogenic acid, cichoric acid 
and echinacoside as the content compounds present in the alcoholic extracts of Echinacea 
species. 
 To the most significant Echinacea species, Echinacea purpurea, Echinacea angustifolia 
and Echinacea pallida  belong. Their importance lies in: 
• the content of a wide range of effective compounds such as alkamides, caffeic acid 
derivatives, polyacetylenes and polyenes, polysaccharides and flavanoids 
• Echinacea species show antioxidative, antibacterial, antiviral and antifungal properties. 
More recently, Echinacea has been studied even as an inhibition of HIV replication.  
• Echinacea occupies a fundamental place between herbal plants, that have been more 
and more used in a treatment of various diseases. 
 
 Seven Echinacea products were analysed to find and compare the total concentrations 
of the content compounds and the concentrations of the individual caffeic acid derivatives. 
The analysed Echinacea products were: 
− Echinacea Aktiv bylinne kapky (Aromatica, v.o.s.) 
− Echinaceove bylinne kapky (Aromatica, v.o.s.) 
− Echinacea Forte (Dr. Theiss Naturwaren GmbH.) 
− Echinaceove bylinne kapky (Mgr. Magda Hajkova) 
− Imunit Echinacea kapky (Simply You, a.s.) 
− Echinacea Kräutertropfen (Dr. Theiss Naturwaren GmbH.) 
− Succus Echinaceae (Phytopharm Kleka S.A.) 
 
 By evaluating the measured data, following conclusions were made: 
• Imunit Echinacea kapky from Simply You, a.s. contained the highest total concentration 
of the content compounds with a great difference from products on the 3rd to 7th places. 
• The second highest content of all present compounds was detected in  Echinaceove 
bylinne kapky from Aromatica, v.o.s.  
• Echinacea Forte from Dr. Theiss Naturwaren GmbH. was placed on the 3rd position. 
• Absolutely the lowest concentration of the content compounds was found in Echinacea 
Kräutertropfen from Dr. Theiss Naturwaren GmbH. 
• The highest content of chlorogenic acid was found in the following three products: 
1st - Echinacea Forte (Dr. Theiss Naturwaren GmbH.), 2nd - Succus Echinaceae 
(Phytopharm Kleka S.A.), 3rd - Imunit Echinacea kapky (Simply You, a.s.) 
• The highest common content of caffeic and cichoric acids was found in the following 
three products: 1st - Imunit Echinacea kapky (Simply You, a.s.), 2nd - Echinaceove 
bylinne kapky (Aromatica, v.o.s.), 3rd - Echinacea Aktiv bylinne kapky (Aromatica, 
v.o.s.) 
• The highest content of echinacoside was found in the following three products: 
1st - Imunit Echinacea kapky (Simply You, a.s.), 2nd - Echinaceove bylinne kapky 
(Aromatica, v.o.s.), 3rd - Echinacea Forte (Dr. Theiss Naturwaren GmbH.) 
 
 As the next step in the experimental part, the determination of the total compounds content 
and echinacoside content in Echinacea extracts was made. The extracts were produced 
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by pressurized solvent extraction from Echinacea purpurea under various conditions. 
Application of PSE to Echinacea species has not been published till this time. 
 Following conditions were found as the best: 
• Extraction at 80 °C and 15 kPa using a mixture of ethanol/water (40/60, v/v) as a solvent 
system gave the most concentrated samples at all. 
• Extraction at 60 °C and 15 kPa using a mixture of ethanol/water (40/60, v/v) 
as a solvent system is proper for a leaf and bloom material, while root material is better 
to be extracted in ethanol/water (60/40, v/v). 
• When extracting at 40 °C and 15 kPa using a solvent system of ethanol/water 
(40/60, v/v), more concentrated samples were obtained from roots. In the case 
of leaves and blooms, it is good to use ethanol/water (60/40, v/v). 
• The highest content of echinacoside was observed in the root extracts as well as 
leaf-bloom extracts prepared in ethanol/water = 40/60 at 80 °C and 15 kPa. 
 
 Isocratic method applied to the separation of the individual compounds in the real samples 
was showed to be unsatisfacory. The determination of the components by high-performance 
liquid chromatography using a gradient elution can be a base for the next diploma thesis. 
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7. LIST OF SYMBOLS 
 
AD air-drying 
AGP arabinogalactan-protein 
AIDS Acquired Immune Deficiency Syndrome 
Ala alanine 
Ara arabinose 
Arg arginine 
Asp aspartic acid 
Asx asparagine/Aspartic acid 
ATR-IR Attenuated Total Reflection Infrared Spectroscopy 
CD cyclodextrin 
CD-MEKC cyclodextrin-modified micellar electrokinetic chromatography 
Da dalton = 1,66053.10-27 kg 
DAD Diode-Array Detector 
DCQAs dicaffeoylquinic acids  
DNA deoxyribonucleic acid 
E. Echinacea 
ESI-MS Electrospray Ionization Mass Spectrometry 
FAB-MS Fast Atom Bombardment – Mass Spectrometry 
FAB-MS-MS Fast Atom Bombardment Tandem Mass Spectrometry 
FD freeze-drying 
Gal galactose 
GC-MS Gas Chromatography/Mass Spectrometry 
Glc glucose 
Glu glutamic acid 
Glx glutamine/Glutamic acid 
Gly glycine 
His histidine 
HIV Human Immunodeficiency Virus 
HP-beta-CD hydroxypropyl-beta-cyclodexrin 
HPLC High-Performace Liquid Chromatography 
Hyp hydroxyproline 
Ile isoleucine 
Isoleu isoleucine 
K root extract 
LC-MS-MS Liquid Chromatography – Mass Spectrometry – Mass Spectrometry 
Leu leucine 
LK leaves and blooms extract 
Lys lysine 
Man mannose 
MEKC Micellar Electrokinetic Chromatography 
Met methionine 
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NIR Near Infrared Reflection 
PBMC peripheral blood mononuclear cells 
Phe phenylalanine 
PLS partial least squares 
ppm parts per million 
Pro proline 
PSE Pressurized Solvent Extraction 
Rha rhamnose 
RP-LC Reverse-Phase Liquid Chromatography 
SC sodium cholate 
SDC sodium deoxycholate 
SDS sodium dodecyl sulphate 
Ser Serine 
Thr threonine 
TLC Thin Layer Chromatography 
Tyr tyrosine 
U.S. The United States  
U.S.$. American dollar 
UV Ultraviolet Light 
Val valine 
VMD Vacuum Microwave Drying 
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8. ATTACHMENTS 
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Attachment 9.1 Overview of Analytical Parameters from Captures no. 2.11 – 2.12 
 
Elution Flow Rate 
Active compound Column Mobile phase 
Temperature 
 Sample Inject 
Amount  
UV 
Detection 
Reference 
40 % ACN, then  
a linear gradient to 
80 % ACN over 
30 min. 
the total run time is 
30 min. The post-run 
time required to 
recycle the system to 
the initial conditions 
is 5 min 
1.0 mL.min-1 polyacetylenes 
 
LiChroprep RP-18 
 
water/acetonitrile 
(ACN) 
 
20 °C - 
210 nm [4] 
isocratically 
50 % A/50 % B 
 
A=1% trifluoroacetic
acid in water 
 
B=1% trifluoroacetic
acid in acetonitrile 
1.5 mL.min-1 
alkamides 
Haisil 100 C-18 column
150×100 mm 
5 μm particle size 
100 Å pore size 
1% trifluoroacetic 
acid in water/1% 
trifluoroacetic 
acid in acetonitrile 
- 250 μl 
the peak 
elutes from 
the column 
at 16.5 min 
[16] 
 
In the cells where symbol “–” appears, any appropriate information were not found. 
 
 
 
 I 
Attachment 9.1 Overview of Analytical Parameters from Captures no. 2.11 – 2.12 - continuation 
 
Elution Flow Rate 
Active compound Column Mobile phase 
Temperature  Sample Inject Amount 
UV 
Detection 
Reference 
A=1% acetic acid in 
nanopure water 
 
B=HPLC grade 
Acetonitrile 
 
0–4 min: 90 % A 
(10 % B) 
4–15 min: 90–60 % A 
(10–40 % B) 
15–30 min: 60–40 % A 
(40–60 % B) 
30–35 min: 0 % A 
(100 % B) 
35–43 min: 90 % A 
(10 % B) 
0.2 mL.min-1 
caffeic acid derivatives 
HP1100 (Agilent, Palo 
Alto, CA, USA) with 
a short, narrowbore  
C-18 column 
50×2.1 mm 
3 μm particle size 
110 Å ore size 
 
0.5 μm precolumn filter
 
1% acetic acid in 
nanopure water/ HPLC 
grade acetonitrile 
- 10 μl 
- [16] 
isocratically 1.0 mL.min-1 
echinacoside 
C-18 Capcell-ACR 
analytical column 
150×4.6 mm 
5 μm particle size 
 
C-18 Security guard 
4.0×3.0 mm 
5 μm particle size 
Phenomenex 
acetonitrile/ 
0.5% acetic acid 
(15.5:84.5, v/v) 
25 °C 80 μL 
absorption 
maxima  
at 218 and 
330 nm 
[30] 
 
In the cells where symbol “–” appears, any appropriate information were not found. 
 II 
 
Attachment 9.1 Overview of Analytical Parameters from Captures no. 2.11 – 2.12- continuation 
 
Elution Flow Rate 
Active compound Column Mobile phase 
Temperature 
 Sample Inject 
Amount  
UV 
Detection 
Reference 
linear gradient 
40–80 % CH3CN/H2O 
over 45 min 
1.0 mL.min-1 
isobutylamides 
YMC-Pack ODS-AM 
RP C-18 column 
250×4.6 mm 
5 μm particle size 
water/acetonitrile 
 
- - 
UV spectra 
collected 
between 
200–400 nm 
[35] 
isocratically 
10-min equilibration 
period was used between 
samples, requiring about 
40 min/sample 
1.0 mL.min-1 tocopherols  
(Echinacea seed oils) 
Waters 840 system, 
Milford, MA,USA 
normal phase column 
4.6×150 mm 
5 μm particle size 
hexane/2-propanol/ 
dimethylpropane 
(1000/5/1, v/v/v) 
25 °C - 
297 and 
325 nm 
[41] 
5–45 % B linearly 
for 20 min followed 
by 45–100 % B linearly 
for 20–25 min 
1.0 mL.min-1 caffeic acid derivatives
alkamides 
Varian Model 5000 
HPLC apparatus 
(ICI Spherisorb 
S10ODS2 analytical 
column, Pellicular ODS 
guard column) 
A = water + 
0.03 mol.dm-3 
phosphoric acid 
 
B = acetonitrile + 
0.03 mol.dm-3 
phosphoric acid - - 
330 and 
254 nm 
[49] 
acetonitrile/water 40/60 
(v/v) to 80/20 (v/v) 
in 40 min 
1.0 mL.min-1 
alkamides 
C-18 column 
15×4.6 mm 
5 μm particle size 
Phenomenex Kromasil 
acetonitrile/water 
- 20 μl 
210 and 
254 nm 
[58] 
 
In the cells where symbol “–” appears, any appropriate information were not found. 
 III 
 
2
400 
 
 
Attachment 9.2 Chromatogram – caffeic (20 µg.mL-1, index 1) and cichoric 
(150 µg.mL-1, index 2) acids standard solutions; 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), 
mobile phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 
35 °C, detection at 330 nm 
 
 
 
Attachment 9.3 Chromatogram – a mixture of caffeic (35 µg.mL-1, index 1) and cichoric 
(35 µg.mL-1, index 2) acids standard solutions; 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), mobile 
phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 0.5 mL.min-1, 35 °C, 
detection at 330 nm 
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Attachment 9.4 Chromatogram – standard solutions of caffeic acid derivatives; 
1 – chlorogenic acid (12 µg.mL-1), 2 – caffeic acid (20 µg.mL-1), 
3 – cichoric acid (110 µg.mL-1), 4 – echinacoside (10 µg.mL-1); 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), 
mobile phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 
35 °C, detection at 330 nm 
 
 
 
Attachment 9.5 Chromatogram – Imunit Echinacea kapky (Simply You, a.s.) ten-times diluted 
in water; 1 – chlorogenic acid, 2 – caffeic and cichoric acids, 
3 – echinacoside; 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), mobile 
phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 35 °C, 
detection at 330 nm 
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Attachment 9.6 Chromatogram – Echinaceove bylinne kapky (Aromatica, v.o.s.) ten-times 
diluted in water; 1 – chlorogenic acid, 2 – caffeic and cichoric acids, 
3 – echinacoside; 
conditions: Supelcosil™ LC-18-DB column (25 cm ×4.6 mm; 5 µm), mobile 
phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 35 °C, 
detection at 330 nm 
 
 
 
Attachment 9.7 Chromatogram – Echinacea Forte (Dr. Theiss Naturwaren GmbH.) ten-times 
diluted in water; 1 – chlorogenic acid, 2 – caffeic and cichoric acids, 
3 – echinacoside; 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), mobile 
phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 35 °C, 
detection at 330 nm 
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Attachment 9.8 Chromatogram – PSE extract F2 (3LKb) six-times diluted in water; 
1 – echinacoside; 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), 
mobile phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 
35 °C, detection at 330 nm 
 
 
 
Attachment 9.9 Chromatogram – PSE extract C2 (3Kb) two-times diluted in water; 
1 – echinacoside; 
conditions: Supelcosil™ LC-18-DB column (25 cm × 4.6 mm; 5 µm), 
mobile phase MeOH/H2O/CH3COOH = 25/75/1, flow rate 1.0 mL.min-1, 
35 °C, detection at 330 nm 
0 5 10 15 20 25
0 
200 
400 
600 
      
  
    
  
  
 
    
V
ol
ta
ge
 [m
V
] 
1
Time [min.]
 
 
  0.8 
0 5 10 15 20 25
0.0 
0.2 
0.4 
0.6 
  
 
       
 
  
 
  
    
V
ol
ta
ge
 [m
V
] 
1 
Time [min.]
 
 VII 
